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Abstract
Canine idiopathic epilepsy is a common neurological disease affecting both purebred and crossbred dogs. Various
breed-specific cohort, epidemiological and genetic studies have been conducted to date, which all improved our
knowledge and general understanding of canine idiopathic epilepsy, and in particular our knowledge of those
breeds studied. However, these studies also frequently revealed differences between the investigated breeds with
respect to clinical features, inheritance and prevalence rates. Awareness and observation of breed-specific differences is
important for successful management of the dog with epilepsy in everyday clinical practice and furthermore may
promote canine epilepsy research. The following manuscript reviews the evidence available for breeds which have
been identified as being predisposed to idiopathic epilepsy with a proven or suspected genetic background, and
highlights different breed specific clinical features (e.g. age at onset, sex, seizure type), treatment response, prevalence
rates and proposed inheritance reported in the literature. In addition, certain breed-specific diseases that may act as
potential differentials for idiopathic epilepsy are highlighted.
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Introduction
Canine idiopathic epilepsy is a common neurological
disease and has been recently defined as two or more
unprovoked seizures at least 24 h apart with no identifi-
able underlying etiology other than a suspected genetic
origin. Idiopathic epilepsy still represents a diagnosis of
exclusion and an appropriate diagnostic workup is es-
sential as a correct diagnosis impacts treatment and
breeding decisions [1]. Affected dogs most often require
life-long antiepileptic medication and regular control
visits. Consequently, the daily lives of many owners are
affected by concerns related to their pet’s seizures and
the changes in daily routine [1–4]. Furthermore, canine
idiopathic epilepsy is a disease, which is characterised by
a broad array of clinical signs, age of onset, and at least
in part underlying genetic backgrounds (see also Tables 1
and 2) [5, 6]. In recent years, idiopathic epilepsy with a
proven or suspected genetic background has been re-
ported for a number of purebred dogs with most studies
focusing on clinical characteristics and genetic aspects.
However, most studies have not yet identified causative
gene mutations, suggesting that, either the research
group in question did not have resources or availability
to go from clinical to genetic identification of mono-
genic epilepsy-causing genes or that inheritance may be
complex, involving several or many susceptibility genes,
and be reflective of additional environmental interac-
tions similar to what is proposed for many human gen-
etic epilepsies [5–7]. The individual dog's response to
antiepileptic treatment may also be complex and in
some individuals, successful antiepileptic drug treatment
presents a time- and cost-consuming challenge with an
increased risk for poor quality of life, premature death
or euthanasia when seizures cannot be adequately
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controlled [8–13]. Estimated prevalence data among the
general dog population have been reported with variable
results [14–17]. The true prevalence of epilepsy in dogs
is unknown and has been estimated to be 0.6–0.75 % in
general dog population [16, 18]. However, prevalence
rates may differ considerably when looking at hospital
populations with prevalence rates of 0.5 − 5 % in non-
referral population and of 1–2.6 % in referral hospital
population [14–17, 19–22]. In breeds, which are predis-
posed to idiopathic epilepsy, considerable higher preva-
lence rates are reported [23–26] than the prevalence
estimated for the general dog population (see Table 3.),
which is one of the reasons a genetic component is sus-
pected in certain canine breeds. Current data show that
the clinical courses, seizure semiology, treatment re-
sponses and heritability may differ substantially between
dog breeds and also between geographically distinct
populations of the same breed, which further highlights
the complexity of the disease. In summary, knowledge
and consideration of these breed-specific (or even
population-specific) differences is important, as this may
potentially impact the choice of treatment regimen,
prognosis for the patient and advice given to owners of
an epileptic dog. In the future breed-specific knowledge
and epileptic syndromes may be defined in further detail
which may not only advance future research in identify-
ing causative gene mutations but also may support the
development of “personalised” or “breed-specific” treat-
ment concepts. The following manuscript reviews dog
breeds, which have been identified as being predisposed
to idiopathic epilepsy, with a special focus on different
epilepsy phenotypes regarding clinical features, treat-
ment response and inheritance. In addition, certain
breed-specific diseases that may act as potential differen-
tials for idiopathic epilepsy are highlighted. The seizure
terminology used in the original studies has been
adapted and uniformed (as far as possible) in line with
the new Guidelines for Epilepsy Definition, Classification
and Terminology in Companion Animals throughout
the manuscript.
Australian Shepherd
In the current literature, there is one specific study of idio-
pathic epilepsy in Australian Shepherds available [9]. This
longitudinal German cohort study was published in 2012
and includes detailed data for 50 affected Australian Shep-
herds (from Germany, Switzerland and Austria). Fifty un-
affected Australian Shepherds served as control dogs.
Idiopathic epilepsy was defined as recurrent seizures
(≥2 seizures ≥ 4 weeks apart), age at onset ≤ 5 years,
Table 1 Depicting breed-specific data regarding age of seizure onset
Breed Age at seizure onset Reference
Australian Shepherd 2.5 years (median) Weissl et al. 2012 [9]
Belgian Shepherd 3.3 years (mean) Berendt et al. 2008 [23]
3.3 years (mean) Seppala et al. 2012 [34]
Bernese Mountain dog 26.5 months (mean) Kathmann et al. 1999 [45]
Border Collie 2.5 years (median) Hülsmeyer et al. 2010 [8]
Border Terrier 3.2 years (mean) Kloene et al. 2008 [56]
Dalmatian 2.9 years (median), 3.2 years (mean) Licht et al. 2002 [65]
English Springer Spaniel 3 years (median) Patterson et al. 2005 [74]
Finnish Spitz 3 years (median) Viitmaa et al. 2013 [82]
Golden Retriever 27.5 months (mean) Srenk et al. 1994 [84]
24.9 months (mean) Lengweiler&Jaggy 1999 [86]
Hungarian (Magyar) Vizsla 3 years (median) Patterson et al. 2003 [87]
Irish Wolfhound by the age of 3 years in 73 % of dogs Casal et al. 2006 [24]
Italian Spinone 38 months (mean) De Risio et al. 2015 [93]
Labrador Retriever 30.6 months (mean) Jaggy et al. 1998 [95]
34 months for males and 28 months for females (mean) Heynold et al. 1997 [94]
by the age of 4 years in 76 % of dogs Berendt et al. 2002 [26]
Lagotto Romganolo 6.3 weeks (mean) Jokinen et al. 2007 [105]
Petit Basset Griffon Vendeen 2 years (median) Gulløv et al. 2011 [25]
Shetland Sheepdog predominantly between 1 and 1.5 years Morita et al. 2002 [109]
Standard Poodle 3.7 years (median) Licht et al. 2007 [113]
2.4 years (median), 2.8 years (mean) Licht et al. 2002 [65]
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Table 2 Depicting breed-specific data regarding seizure type and seizure remission
Breed Seizure type History of cluster seizures or
status epilepticus
Remission rate Reference
Australian Shepherd 36 % generalised epileptic seizures 20 % cluster seizures 12 % Weissl et al. 2012 [9]
26 % focal epileptic seizures evolving into
generalised seizures
12 % status epilepticus
38 % both seizure types 48 % history of both
52 % showed also focal epileptic seizures
(in addition to their generalised epileptic
seizures or focal
epileptic seizures evolving into
generalised seizures)
Belgian Shepherd 18 % generalised epileptic seizures n.s. n.s. Berendt et al. 2008 [23]
25 % focal
53 % focal epileptic seizures evolving into
generalised seizures
4 % unclassified
6 % generalised epileptic seizures n.s. n.s. Berendt et al. 2009 [41]
83 % focal epileptic seizures or focal
epileptic seizures evolving into
generalised seizures
11 % unclassified
n.s. 33 % cluster seizures 13.7 % Gulløv et al. 2012 [37]
18 % generalised epileptic seizures 33 % cluster seizures n.s. Seppala et al. 2012 [34]
7 % focal epileptic seizures
37 % focal epileptic seizures evolving into
generalised epileptic seizures
34 % generalised epileptic seizures with
unknown onset
4 % unclassified
Bernese Mountain dog 98 % generalised epileptic seizures n.s. n.s. Kathmann et al. 1999 [45]
2 % focal epileptic seizures
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
Border Collie 8 % generalised epileptic seizures 45 % cluster seizures 18 % Hülsmeyer et al. 2010 [8]
78 % focal epileptic seizures evolving into
generalised seizures
4 % status epilepticus
14 % unclassified 49 % history of both
45 % showed also focal epileptic seizures
(in addition to their generalised epileptic
seizures or focal epileptic seizures evolving
into generalised seizures)
Border Terrier 68 % generalised epileptic seizures n.s. n.s. Kloene et al. 2008 [56]
32 % focal epileptic seizures
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
Cavalier King Charles 39 % generalised epileptic seizures n.s. n.s. Driver et al. 2013 [59]
36 % focal epileptic seizures
25 % focal epileptic seizures evolving into
generalised seizures
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Table 2 Depicting breed-specific data regarding seizure type and seizure remission (Continued)
Collie (rough and smooth) Predominantly generalised 35 % cluster seizures n.s. Munana et al. 2012 [64]
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
Dalmatian 20 % generalised epileptic seizures 63.6 % cluster seizures n.s. Licht et al. 2002 [65]
80 % focal epileptic seizures or focal
epileptic seizures evolving into
generalised seizures
English Springer Spaniel 47 % generalised epileptic seizures 38 % cluster seizures n.s. Patterson et al. 2005 [74]
33 % focal epileptic seizures
20 % focal epileptic seizures evolving into
generalised seizures
Finnish Spitz 1 % generalised epileptic seizures 16.2 % cluster seizures n.s. Viitmaa et al. 2013 [82]
54 % focal epileptic seizures
31 % focal epileptic seizures evolving into
generalised seizures
7 % generalised with unknown onset
7 % completely unclassified
Golden Retriever 83 % generalised epileptic seizures n.s. n.s. Lengweiler&Jaggy 1999 [86]
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
92 % generalised epileptic seizures n.s. n.s. Srenk et al. 1994 [84]
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
Hungarian (Magyar) Vizsla 21 % generalised epileptic seizures n.s. n.s. Patterson et al. 2003 [87]
62 % focal epileptic seizures
17 % focal epileptic seizures evolving into
generalised seizures
Irish Wolfhound Predominantly generalised epileptic seizures n.s. n.s. Casal et al. 2006 [24]
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
Italian Spinone 23 % generalised epileptic seizures n.s. DeRisio et al. 2015 [93]
51 % focal epileptic seizures evolving into
generalised seizures
26 % generalised epileptic seizures with
unknown onset
Labrador Retriever 24 % generalised epileptic seizures n.s. n.s. Berendt et al. 2002 [26]
70 % focal epileptic seizures or focal
epileptic seizures evolving into
generalised seizures
91 % generalised epileptic seizures n.s. n.s. Heynold et al. 1997 [94]
9 % focal epileptic seizures
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
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unremarkable laboratory results (CBC, biochemical
profile, pre- and postprandial serum bile acids concen-
tration), and normal interictal neurologic examination
performed by the study investigators or a specialist in
veterinary neurology. Magnetic resonance imaging
(MRI) and cerebrospinal fluid (CSF) analysis were
strongly recommended and obligatory if the age of on-
set was < 6 months. Dogs with a history of head trauma
or structural brain disease were excluded. Advanced
diagnostic imaging and CSF analysis were performed in
42 % of affected dogs [9]. Prevalence data for this breed
yet are not reported. The median age at seizure onset
was 2.5 years [9]. Among epileptic dogs, 64 % were
males and 36 % females. The seizure type was specified
as (primary) generalised epileptic seizures in 36 % of
dogs and as focal epileptic seizures evolving into gener-
alised seizures in 26 % of dogs; the remaining dogs
(38 %) showed both seizure types [9]. In addition to
their (primary or secondary) generalised seizures, 52 %
of dogs also experienced focal seizures [9]. Focal sei-
zures often presented with focal tremors, salivation,
dilated pupils, and lateral head turn. Concomitant
or solitary episodes with variable states of awareness
and behavioural changes like panic attacks, sporadic ag-
gressiveness, pacing, staring, or adverse reactions to
emotive words were common [9]. Exclusively discrete
seizures (single seizure per day) occurred in 20 % of
dogs; of the remaining dogs 20 % had a history of clus-
ter seizures, 12 % had a history of status epilepticus,
and 48 % of dogs had a history of both. In summary,
68 % of dogs had a history of cluster seizures and 60 %
of dogs a history of status epilepticus [9]. An important
observation was that in 28 % of dogs the first seizure
event presented as a cluster seizure or status epilepti-
cus. Although severe clinical courses (high incidence of
cluster seizures and status epilepticus) were frequently
reported among Australian Shepherds, seizure remis-
sion was obtained in 12 % of dogs (6 % with and 6 %
without antiepileptic treatment) [9], which is in line
with remission rates reported in other canine epilepsy
studies [8, 10, 11, 27]. The treatment response was re-
ported to be poor (≥1 seizure day/month) in 56 % of
Australian Shepherds (treatment response was only
assessed for dogs that were treated sufficiently with
phenobarbital alone or in combination with other
AEDs; which was the case in 70 % of the study popula-
tion) [9]. Phenobarbital serum concentrations did not
differ between dogs with good seizure control and dogs
with poor seizure control [9]. Among the deceased
dogs (30 % of the population) the median age at death
Table 2 Depicting breed-specific data regarding seizure type and seizure remission (Continued)
96 % generalised epileptic seizures n.s. n.s. Jaggy et al. 1998 [95]
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
Lagotto Romagnolo Mainly focal epileptic seizures n.s. by 8–13 weeks
of age
Jokinen et al. 2007 [105]
Petit Baset Griffon Vendeen 5 % generalised epileptic seizures n.s. n.s. Gulløv et al. 2011 [25]
41 % focal epileptic seizures
52 % focal epileptic seizures evolving into
generalised seizures
2 % unclassified
Shetland Sheepdog Predominantly generalised epileptic seizures n.s. n.s. Morita et al. 2002 [109]
Distinction between (primary) generalised
epileptic seizures and focal epileptic seizures
evolving into generalised seizures was
not performed.
Standard Poodle 3.5 % generalised epileptic seizures n.s. n.s. Licht et al. 2007 [113]
33 % focal epileptic seizures
60 % focal epileptic seizures evolving into
generalised seizures
3.5 % generalised epileptic seizures with
unknown onset
Predominantly focal epileptic seizures or
focal epileptic seizures evolving into
generalised seizures
34 % cluster seizures n.s. Licht et al. 2002 [65]
n.s. not specified
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was 3.1 years [9]. The identification of a causative gene
mutation has not yet been reported, but a common
founder of 29 affected Australian Shepherds and a clus-
tering manifestation in littermates, full or half siblings
was detected [9]. An important observation of this
study was, that during the case recruitment phase, a
large subset of dogs were reported with recurrent
episodes of altered mentation, bizarre behavioural ac-
tivity and autonomic signs, which corroborated suspi-
cion for potential focal seizures. None of those dogs
experienced generalised seizures and in most cases
diagnostic work-up was lacking because the neuro-
logical signs were mild. Thus, these animals were in-
cluded as neither case nor control dogs. However,
Table 3 Depicting breed-specific epilepsy prevalence estimates
Breed Prevalence Country Number of dogs Study information/Epilepsy definition Reference
Belgian Tervueren 17 % USA Complete records of 997 dogs containing 170
epileptic dogs. Data collection late 1980s.
Dogs were included as epilepsy cases when
they experienced at least one seizure. Only dogs,
which were at least five years of age at the time
of the survey were included in the analysis to
avoid censoring those individuals, which may
have had their first seizure later in life.
Famula et al.
1997 [38]
Belgian Shepherd
(Tervueren and
Groenendael)
9.5 % Denmark 1.248 registered dogs in the Danish
Kennel Club, representative sample with
interview of 516 dog owners identifying
49 epileptic dogs. Data collection
1995–2004.
Dogs that had experienced two or more
seizures were defined as epilepsy cases.
Berendt et al.
2008 [23]
Belgian Shepherd
(Tervueren and
Groenendael)
33 % Denmark 199 family members (152 Groenendael
and 47 Tervueren) containing 66 epileptic dogs
(53 Groenendael & 13 Tervueren). Data
collection 1988–2005.
Dogs that had experienced two or more
seizures were defined as epilepsy cases.
Berendt et al.
2009 [41]
One large family
Border Terrier 13,1 % Germany Records of 365 dogs containing 47 epileptic
individuals. Data collection from 1986–2000.
Not provided Kloene et al.
2008 [56]
Irish Wolfhound 18.3 % USA 796 Irish Wolfhounds from 115 litters
with 146 identified epilepsy cases.
Dogs that had experienced more than
2 seizures. Average inbreeding coefficient
(calculated throughout 10 generations) for all
the dogs entered into the study was 0.156.
Casal et al.
2006 [24]
Labrador Retriever 3.1 % Denmark 29.602 Danish Labrador retrievers registered
in the Danish Kennel Club in a 10-year period.
From the reference population a representative
sample of 550 dogs were selected for by
random sampling stratified by year of birth.
After questionnaire interviews of all 550
dog-owners and clinical investigation of
epilepsy suspected dogs, 17 dogs were finally
identified with idiopathic epilepsy. Data
collection 1989–1999.
Dogs that had experienced two or more
recurrent seizures.
Berendt et al.
2002 [26]
Petit Basset Griffon
Vendeen (PBGV)
8.9 % Denmark 876 PBGV dogs registered in the Danish
Kennel Club (56 dogs were exported), 471
owner interviews identified 42 epileptic
individuals. Data collection 1999–2008.
Dogs that had experienced at least 2
seizures with a minimum interval of 24 h.
Gulløv et al.
2011 [25]
Finnish Spitz Dog 5.4 % Finland The epilepsy prevalence was calculated for
the dogs that were living when their owners
answered a questionnaire (111 epilepsy
cases/2.069 total dogs). The questionnaire
was sent to all owners of 1- to 10-year-old
dogs during the period from June 2003 to
July 2004.
Dogs that had experienced at least 2
seizure episodes without interictal
neurologic abnormalities.
Viitmaa
et al.
2013 [82]
Italian Spinone 5.3 % UK The owners of all UK Kennel Club registered
Italian Spinoni born between 2000 and 2011
(n = 3331) were invited to participate in the
study. Of these, 1192 returned the phase I
questionnaire and 63 dogs (5.3 %) were
identified with idiopathic epilepsy. Of the
remaining dogs 0.6 % were identified with
structural epilepsy, 0.6 % were identified
with reactive epileptic seizures and 1.5 % had
unclassified epilepsy.
Recurrent seizures (≥2 seizures occurring >24 h
apart) with an onset between 6 months and
6 years of age in dogs with normal interictal
physical and neurologic examinations and
results of a CBC and biochemistry profile within
the normal reference range.
DeRisio
et al.
2015 [93]
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based on those findings and in contrast to the above-
mentioned frequent severe clinical courses a distinct
mild and focal epilepsy course cannot be excluded for
the Australian Shepherd breed and may need to be fur-
ther elucidated in the future [9]. Identified risk factors:
The median age of seizure onset was lower in non-
merle-coloured (1.8 years) than in merle-coloured
(2.8 years) dogs [9]. Seizure control was associated with
age at seizure onset (older age with better seizure con-
trol) and coat colour (merle dogs with better seizure
control) but appeared unrelated to the ABCB1 (MDR1)
genotype (when interpreting the latter finding, it needs
to be considered that out of all the epilepsy cases
only one dog was determined to be homozygous for
the ABCB1-1Δ mutation) [9]. Seizure remission oc-
curred independently of the clinical course and seizure
frequency [9]. No association was found between seiz-
ure control, phenobarbital serum concentration and the
number of administered drugs, indicating that there
may be a subcategory of severe intrinsic epilepsy in
Australian Shepherd dogs [9]. Reduced survival times
were found in dogs with poor seizure control, in dogs
<2 years of age at seizure onset, in dogs experiencing ≥
10 seizure days within the first six months after seizure
onset and in non-merle coloured dogs [9]. However, in
a multivariable COX regression analysis only a high ini-
tial seizure frequency (≥10 seizure days/6 months after
seizure onset) and poor seizure control remained statis-
tically significant with respect to reduced survival
times. Overall, dogs with good seizure control had a
lower risk of death than dogs with poor seizure control
[9]. Potential breed-specific diseases that may mimic
idiopathic epilepsy: Neuronal ceroid lipofuscinosis
(NCL), a neurodegenerative storage disorder, may also
manifest with epileptic seizures and/or fly-biting epi-
sodes and therefore may present a potential differential
in young Australian Shepherds with seizures. However,
NCL usually manifests with concurrent severe neuro-
logical and/or cognitive abnormalities and seizures usu-
ally occur late in the disease course [28]. A gene test
for NCL in Australian Shepherds is available (missense
mutation in the CLN6 gene) [29]. One study from
2011, diagnosed two Australian Shepherds with
exercise-induced collapse (EIC), which also may mimic
a seizure event, and therefore should be considered as
a potential differential to epileptic seizures. However, a
dynamin-1 (DNM1)-gene-mutation was not detected in
those two Australian Shepherds [30]. EIC usually is trig-
gered by strenuous physical exercise and consciousness
usually remains preserved during episodes, which may help
to clinically differentiate between epileptic seizures and EIC
[30]. Furthermore, the Australian Shepherd breed has a
high frequency of the ABCB1-gene mutation (nt230 (del4))
that results in non-functional P-glycoprotein (P-gp)
expression and neurotoxicity to drugs, which are P-gp sub-
strates [31, 32]. This may need to be considered as a differ-
ential for idiopathic epilepsy in Australian Shepherd dogs
that present with acute epileptic seizures and potential pre-
vious exposure to neurotoxic P-gp substrates. The fre-
quency of dogs homozygous for the mutant allele is
reported to range between 1.7 − 25 % depending on the re-
spective study and geographic area [33].
Belgian Shepherd (mainly Groenendal and Tervueren
variants)
There are ten different studies available that focus specific-
ally on idiopathic epilepsy in the Belgian Shepherd (mainly
Groenendal and Tervueren variants) [23, 34–42]. This rela-
tively high number of studies leaves the Belgian Shepherd
as one of the most intensively studied dog breeds in the
field of canine epilepsy. Interestingly, an inheritance of idio-
pathic epilepsy in this breed was first suggested in 1968
[42]. All of the available studies respectively focus on seiz-
ure semiology, prevalence, mode of inheritance and gene
mutation identification; and have been conducted mainly in
Denmark [23, 37, 41], the United States [35, 36, 38–40] and
Finland [34]. The variability in results between individual
studies may be attributed to the examination of geographic-
ally and genetically distinct populations and variable study
designs and inclusion and exclusion criteria being applied.
One Danish study published in 2008 was an epidemio-
logical study of a larger population of Belgian Shepherds
registered in the Danish Kennel Club in a 10-year period.
Prevalence was estimated at 9.5 % based on interviews of
516 dog owners, which identified 49 dogs with idiopathic
epilepsy [23]. Mean age at seizure onset was 3.3 years.
However, 39 % of all affected dogs did not experience their
first seizure until after four years of age. Of the investigated
epileptic dogs, 63.3 % were females and 36.7 % were male;
however, a significant gender predisposition was not de-
tected. The seizure type was reported to be focal in 25 % of
dogs, focal evolving into generalisation in 53 % of dogs and
(primary) generalised in 18 % of dogs (in 4 % of dogs sei-
zures could not be classified). The most commonly re-
ported focal seizure phenomenology included ataxia,
crawling, swaying, behaviour suggesting fear, salivation, ex-
cessive attention seeking and disorientation. The median
survival time from seizure onset was 2.5 years among de-
ceased dogs [23]. In 2009 the same authors investigated a
selected large Danish Belgian Shepherd family including
199 individuals with 66 idiopathic epilepsy affected dogs
[41]. The epilepsy prevalence in this selected family was es-
timated at 33 % [41], which showed that accumulation of
epileptic individuals within certain breeding lines can result
in substantially higher prevalence estimates than in the
breed in general (as reflected by the two Danish studies)
[23]. As found in the Danish breed study from 2008, the
seizure type was predominantly (83 % of dogs) defined as
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focal or focal epileptic seizures evolving into generalised sei-
zures, while only 6 % of dogs experienced (primary) gener-
alised epileptic seizures [41]. In 11 % of dogs, seizures could
not be classified. Due to the high prevalence of focal sei-
zures the authors discussed if this familial epilepsy could be
compared to familial focal epilepsy in humans [41]. This
large Danish Belgian shepherd family was further investi-
gated with respect to survival and selected risk factors for
premature death by a longitudinal observational study pub-
lished in 2012 [37]. The life span of epileptic dogs was not
significantly shortened by the presence of epilepsy. Epilepsy
was the predominant cause of death in the population and
epilepsy-related deaths accounted for 70 % of all deaths in
the group of dogs with epilepsy. Two probable sudden un-
expected deaths related to epilepsy occurred in dogs with
generalised seizures. Cluster seizures occurred in 33 % but
did not significantly influence the life span of epileptic dogs.
Dogs with epilepsy had an epilepsy remission proportion of
13.7 % [37]. A 2012 genome wide-association study includ-
ing Belgian Shepherd epilepsy cases from Denmark,
Finland and USA (159 cases and 148 controls) identified a
novel idiopathic epilepsy locus [34]. The mean age at seiz-
ure onset in the dogs participating in the study was 3.3 years
[34], which is in line with findings of the Danish study [23].
The median seizure frequency was 5.25 seizures per year
with some dogs experiencing less than one seizure per year
and others up to 10 seizures per day. One third (33 %) of
the affected dogs had a history of cluster seizures. The seiz-
ure type was defined as focal epileptic seizures evolving into
generalised seizures in 37 % of dogs, as generalised seizures
with unknown onset in 34 % of dogs, as (primary) general-
ised in 18 % of dogs and as focal in 7 % of the dogs. In 4 %
of dogs the seizures remained unclassified [34]. Only 3 % of
the dogs did not respond to antiepileptic drug treatment,
while the remaining dogs all responded at least with some
degree of seizure frequency reduction. A number of dogs
participating in the study had an EEG examination and
interictal EEG revealed epileptiform activity with variable
foci in all examined dogs [34]. Multiple studies have been
conducted with respect to potential modes of inheritance
in this breed, however results were not always consistent
and this again may reflect different study design, inclusion
and exclusion criteria. In the Danish study from 2009 the
mode of inheritance of epilepsy was based on segregation
analysis reported to be simple mendelian with a segregation
pattern resembling autosomal dominant inheritance but
with possible incomplete penetrance [41]. These results
contradict the findings from an older USA study in 2003, in
which a polygenic mode of inheritance influenced by a sin-
gle autosomal recessive locus was suggested [35]. Further-
more a study from 1997 found that a single locus model
does not appear adequate as an explanation [38], but the
same investigators in a 2000 study suggested a single locus
with a large effect on the incidence of seizures [39]. The
1997 USA study estimated the heritability of epilepsy in the
Belgian Shepherd dog at 0.77 [38], and the 1998 USA study
predicted that the offspring of the mating of two non-
epileptic dogs has a probability of 0.99 of never suffering
from a seizure, while the offspring of the mating of two
dogs who have each had one seizure has a predicted prob-
ability 0.58 of never suffering from a seizure [40]. Although,
the clinical phenotype of idiopathic epilepsy in the Belgian
shepherd is well described and extensive research efforts
have been undertaken, it has not yet been possible to iden-
tify causative gene mutation(s) responsible for idiopathic
epilepsy in the breed [34–36]. Identified risk factors: Intact
dogs with idiopathic epilepsy had a significantly increased
risk of being euthanised because of idiopathic epilepsy
compared to neutered dogs with idiopathic epilepsy [23].
Recently, it was found that homozygosity for a two-SNP
haplotype within the ADAM23 gene conferred the highest
risk for idiopathic epilepsy among the investigated Belgian
shepherds [34]. These data suggested that the identified
ADAM23 variant is a polymorphism, but yet needs to be
further confirmed. Potential breed-specific diseases that
may mimic idiopathic epilepsy: In the authors’ experience
the most important differential to be excluded in the Groe-
nendael and Tervueren is a (often exercise induced) epi-
sodic involuntary movement disorder similar to paroxysmal
dyskinesia described in Chinook dogs [43] and Border ter-
riers [44]. It is recommended that the paroxysmal episode
be filmed. The paroxysmal movement disorder can be dis-
tinguished from seizures because the dogs remain respon-
sive to stimuli and their environment, for example will
continue to try to play. The episodes are typically longer in
duration than epileptic seizures and characterised by dys-
tonic limb lifting (all joints in flexion). The dog may be-
come recumbent but often remains standing (personal
communication Clare Rusbridge February 2015).
Bernese Mountain dog
In the current literature, one study about idiopathic epi-
lepsy in Bernese Mountain dogs is available [45]. This
study includes 50 affected dogs from Switzerland and
was published in 1999. Idiopathic epilepsy was diag-
nosed when physical and neurological examination,
haematology, serum biochemistry, urine and CSF ana-
lysis were unremarkable. Detailed data regarding defin-
ition of idiopathic epilepsy were not provided in this
study [45]. Sixty-nine healthy Bernese Mountain dogs
served as control dogs and a possible gender predispos-
ition was analysed by the use of a non-preselected popu-
lation containing 4005 Swiss Bernese Mountain dogs
[45]. Prevalence data have not been reported for this
breed [45]. The mean age of seizure onset was 2.2 years
(26.5 months) with 62 % of dogs exhibited their first
seizure between one to three years of age, 20 % had an
age of seizure onset of less than one year and 18 %
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experienced the first seizure at an age ≥ 3 years [45]. A
gender predisposition for males (62 %) compared to fe-
males (38 %) was observed. The gender ratios (males to
females) were 1.6:1 among epileptic dogs, 1:1.1 among
non-epileptic control dogs and 1:1.4 among all dogs
[45]. The seizure type was defined as generalised in 98 %
of dogs and as focal in 2 % of dogs [45]. However, a de-
tailed differentiation between (primary) generalised sei-
zures and focal epileptic seizures evolving into generalised
epileptic seizures was not conducted, hence some of the
dogs may have experienced focal seizures evolving into
generalisation rather than (primary) generalised seizures.
The seizure frequency was not analysed in detail, but was
reported to range from three seizures per week to one
seizure every year, with 50 % of dogs experiencing more
than one seizure every two months. The results of the
pedigree analyses and binomial test were best compatible
with a polygenic, recessive (possibly sex-modified) mode
of inheritance [45]. The identification of a causative gene
mutation has not yet been reported [45]. Identified risk
factors: The age at seizure onset was significantly lower in
dogs from affected parental animals than in dogs from
healthy parental animals [45].
Border Collie
In the current literature, one specific study about idio-
pathic epilepsy in Border Collies is available [8]. This
study – conducted in Germany – was published in 2010
and provides data regarding clinical characteristics and
heritability of epilepsy among a German Border Collie
population [8]. The latter study, included data of 49
Border Collies diagnosed with idiopathic epilepsy; no
control dogs were included. Idiopathic epilepsy was de-
fined as recurrent seizures (≥2 seizure days at least
4 weeks apart) with an onset between 6 months and
5 years of age in dogs with otherwise normal physical,
laboratory, and neurological characteristics upon exam-
ination. Requested minimal laboratory investigations in-
cluded a CBC and biochemical profile. MRI and CSF
analysis were requested if age at seizure onset was <
6 months or > 5 years of age [8]. Detailed prevalence
data have yet not been provided for this breed [8]. Al-
though detailed prevalence data are not available, the
Border Collie was among the most common affected
breeds in several epidemiological canine epilepsy studies
in the UK [17, 46, 47]. The median age at seizure onset
in the German study was 2.4 years with 74 % of dogs ex-
periencing their first seizure between 1 and 5 years.
However 18 % experienced the first seizure at an age ≤
1 year and 8 % of dogs had an age of ≥ 5 years. No gen-
der predisposition was detected with 49 % males and
51 % females. The seizure type was defined as focal epi-
leptic seizures evolving into generalised seizures in 78 %
of dogs and as (primary) generalised in 8 % of dogs. In
14 % of dogs the seizures remained unclassified, as seiz-
ure onset was not clearly observed. In addition, 45 % of
dogs also had sporadic focal epileptic seizures, which
manifested as sudden uncontrolled head or facial twitch-
ing mostly associated with impaired consciousness. Ac-
tive epilepsy (≥1 epileptic seizure in the last year of the
study or in the year preceding death) was documented
in 82 % of dogs and seizure remission was reported for
18 % of the Border Collies with idiopathic epilepsy,
which is similar to reported remission rates in other dog
populations [9, 11, 27, 47]. However, a recent canine epi-
lepsy study which focussed on identification of clinical
risk factors for remission revealed the Border Collie as
the breed least likely to achieve seizure remission [47].
Of all affected dogs 45 % had a history of cluster sei-
zures, 4 % had a history of status epilepticus and 49 %
had a history of both. Overall, 94 % of all dogs included
in the German study experienced at least one episode of
cluster seizures and 60 % of all dogs had at least one epi-
sode of status epilepticus [8]. A high prevalence of clus-
ter seizures among Border Collies was also found in a
recent study about canine juvenile epilepsy in the UK
[10], however, in contradiction to this data another UK
study reported the Border Collie as being less affected
by cluster seizures (>80 % not clustering) [46]. The me-
dian age at death among the deceased epileptic Border
Collies (47 % of the study population) was 5.2 years [8],
which is more than half that of the general UK Border
Collie population (median age at death 13.5 years) found
in another study [48]. The median survival time from
seizure onset for deceased epileptic Border Collies was
short being only 2.1 years in the German study [8]. This
finding was supported by another study that also found a
significant shorter mean survival time for Border Collies
with idiopathic epilepsy (3.6 years) compared to a general
dog population with idiopathic epilepsy (7.9 years) [10].
Treatment response was reported to be poor (≥1 seizure
day/month) in 71 % of dogs that were treated adequately
(67 % of the study population) with ≥ 2 antiepileptic drugs
[8]. In summary, all above-mentioned clinical data suggest
that this breed may generally have a severe epilepsy course
and epileptic Border Collies are more likely to be eutha-
nised than affected dogs of other breeds. Based on pedi-
gree analysis, 29 affected dogs shared a common ancestor,
indicating a strong genetic background for epilepsy in
Border Collies. The identification of a causative gene mu-
tation has yet to be achieved [8]. Identified risk factors: No
positive impact of neutering on the course of epilepsy was
detected. Comparison between dogs with active epilepsy
and dogs in remission identified significant differences in
age at seizure onset (older age at seizure onset in dogs that
went into remission) and age at death (younger age at
death for dogs with active epilepsy). Furthermore, initial
seizure frequency (during the first 6 months) was
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significantly lower in dogs that went into remission com-
pared to dogs with continuing epilepsy. Reduced survival
times were found in dogs with young age at seizure onset
(≤2 years of age) and dogs with a severe epilepsy course
(occurrence of status epilepticus) [8]. No significant asso-
ciation between survival time and sex, reproductive status
or number of administered drugs was identified. A Swiss
study identified a polymorphism in the ABCB1-gene that
was found to be associated with antiepileptic drug resist-
ance (T >G variation in intron 1) in Border Collies [49].
This ABCB1-polymorphism (T >G variant) was detected
in a later Japanese study with a frequency of 9.8 % among
a Japanese Border Collie population [50]. In contrast to a
known “loss of function” for the nt230 (del4) mutation,
the T >G variation is hypothesised to have an ABCB1
drug transporter”gain of function” and therefore poten-
tially might contribute to drug resistance. However, future
research is required to investigate those associations fur-
ther and also to investigate the possible mechanisms of
this ABCB1-polymorphism on drug resistant epilepsy in
Border Collies. Potential breed-specific diseases that may
mimic idiopathic epilepsy: NCL, a neurodegenerative dis-
order, may also manifest with epileptic seizures and there-
fore may present a potential differential in young Border
Collies presenting with seizures [51–53]. However, NCL is
reported to manifest between the age of 15 and 22 months
[51, 53] with severe and rapidly progressive neurological
signs (e.g. vision impairment, gait abnormalities, dementia,
behavioural abnormalities, aggression). Affected Border
Collis died before the age of 3 years and the latest they
were euthanized after the onset of clinical signs was
6 months [51]. A causative gene mutation for NCL in
Border Collies has been identified and a gene test is avail-
able (mutation in the CLN5 gene) [54]. One study from
2011 reported 20 Border Collies diagnosed with exercise-
induced collapse, but a DNM1-gene-mutation was not ob-
served in any of these Border Collies [30]. However, in
contrast to epileptic seizures, EIC usually is triggered by
strenuous exercise and consciousness usually remains pre-
served during episodes and the dog’s behaviour suggests
discomfort from heat (panting, seeking shade and/or
water), which may help a clinician to differentiate between
these two diseases [30]. The Border Collie breed is also af-
fected by the ABCB1/MDR1-gene mutation (nt230
(del4)), which may need to be considered in dogs with
acute seizures and potential previous exposure to neuro-
toxic P-gp substrates. The frequency of homozygous af-
fected dogs is reported with 0.3 % [33]. There is one
case report describing hyperammonemic encephalopathy
(normal bile acids, but abnormal ammonia tolerance test)
secondary to a hereditary selective cobalamin malabsorp-
tion in a juvenile Border Collie that presented with neuro-
logical signs, such as an abnormal mental state (stupor)
[55]. However, although this particular dog did not seizure,
hyperammonemia may carry a potential risk for reactive
seizures in other Border Collies with such hyperammone-
mic encephalopathy.
Border Terrier
One specific study about epilepsy in Border Terriers that
was conducted in Germany and published in 2008 is
available in the current literature [56]. This study in-
cluded 47 affected dogs and 318 non-affected control
dogs collected by questionnaires send to owners of dogs
registered in the German Terrier Club. Detailed data re-
garding epilepsy definition were not provided [56]. The
prevalence of epilepsy was estimated at 13.1 % among
the investigated population [56]. In line with this high
prevalence, a UK epilepsy prevalence and risk factor
study reported the Border Terrier with a 2.7 times in-
creased odds of epilepsy compared with crossbred dogs
[17]. A gender predisposition was not detected with
53 % males and 47 % females in the German study. The
mean age at seizure onset was 3.2 years. The clinical
course was assessed as mild in most of the dogs (70 %)
with only occasional seizures per year; only 27 % of dogs
suffered from multiple seizures per month. Cluster sei-
zures were documented in 8.5 % of dogs. The seizure
type was defined as generalised epileptic seizures in
68 % of dogs and as focal epileptic seizures in 32 % of
dogs, however a differentiation between (primary) gener-
alised epileptic seizures and focal epileptic seizures
evolving into generalised seizures was not performed. In
17 % of dogs autonomic signs (urination, defecation)
were reported during a seizure and some of the dogs
(27.6 %) experienced preictal signs, such as restlessness,
disorientation, behaviour suggesting fear or seeking
owners’ attention [57]. Hence, according to the new clas-
sification guidelines some of those dogs with a “preictal
phase” (27.6 %) might be reclassified as having focal sei-
zures evolving into generalised seizures. The seizures
were defined as tonic in 46.8 % of dogs, as clonic in
14.9 % of dogs and as tonic-clonic in 38.3 % of dogs. In
51 % of dogs seizures occurred when they were in a rest-
ing position [57]. One important finding was that in
most of the dogs (79 %) consciousness was assessed as
preserved during a seizure, and only 21 % of dogs expe-
rienced an ictal loss of consciousness. Thirty per cent of
dogs were treated with phenobarbital, and in 23.4 % of
dogs, owners subjectively reported at least some clinical
improvement [57]. The identification of a causative gene
mutation has not yet been reported [56]. Potential
breed-specific diseases that may mimic idiopathic epi-
lepsy: Canine epileptoid cramping syndrome (CECS) is
proposed as paroxysmal dyskinesia affecting Border Ter-
riers. Recently, detailed data regarding typical clinical
phenotypes of 29 CECS-affected Border Terriers have
been published [44]. Based on the similarities regarding
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clinical semiology and typical age of disease manifest-
ation, CECS is an important differential to epileptic sei-
zures in this breed; even for experienced clinicians
CECS may mimic a seizure disorder and vice versa. Dis-
tinct phenotypic characteristic of the paroxysmal events
in CECS are generalised tremor, dystonia and difficulty
walking. Episodes were reported to last from 2–30 min
in the majority of dogs and in some up to 150 min [44].
In addition, some owners report signs of gastrointestinal
distress associated with the episodes, including borbo-
rygmi during the episode and vomiting and diarrhoea
before or after the episode in almost 50 % of the dogs.
From a clinical point of view, the assessment of con-
sciousness and the occurrence of autonomic signs such
as urination, defecation or salivation during an episode
may help to differentiate between both diseases, with
CECS usually being characterized by a normal conscious
state and absence of above mentioned autonomous signs
[44]. However, as 79 % of epileptic Border Terriers were
reported to have preserved consciousness during an epi-
leptic seizure in the German study [56] and 62 % of
Border Terriers diagnosed with CECS showed some kind
of “pre- and postcramping” signs (such as eating grass,
vomiting, or seeking to be near owners) [44] diagnosis still
may remain challenging and potential overlapping of both
diseases needs to be further elucidated in the future (e.g.
with ambulatory ictal EEG examinations). With regard to
response to therapy, therapeutic trials with phenobarbital,
potassium bromide, diazepam, butylscopolamin resulted
in no improvement in the majority of CECS affected dogs,
but 50 % of the owners felt improvement after a dietary
change (e.g. change to hypoallergenic diet) [44].
Cavalier King Charles Spaniel
For several years it has been suggested that idiopathic
epilepsy may occur as an independent disease in this
breed and may not be the consequence of the frequently
occurring Chiari-like malformation [58]. This hypothesis
was supported by a study from 2013 that did not find a
significant association between the degree of the Chiari-
like malformation, (such as degree of ventriculomegaly)
and the occurrence of epileptic seizures [59]. However,
an overlapping of the two diseases cannot be entirely ex-
cluded. According to the findings of the study published
in 2013 the seizure type was defined as (primary) gener-
alised epileptic seizures in 39 % of the dogs, as focal epi-
leptic seizures in 36 % and as focal epileptic seizures
evolving into generalised seizures in 25 % of dogs [59].
No detailed data regarding potential modes of inherit-
ance are available; however, epilepsy was found more
frequently in lines originating from whole-colour dogs
[58]. Potential breed-specific diseases that may mimic
idiopathic epilepsy: Cavalier King Charles Spaniels are
also known to suffer from Episodic Falling (paroxysmal
exercise-induced dyskinesia) [60]. Episodic falling is a
movement disorder that typically manifests between the
age of 4 months and four years. Falling episodes are in-
duced by physical activity, stress and excitement and
manifest with hypertonicity of the limbs resulting in in-
ability to move or even complete collapse. In contrast to
epileptic seizures consciousness usually is not affected
during these episodes [60]. A gene test is available for
episodic falling that is based on evidence of a BCAN (bre-
vican) mutation [61, 62]. Older Cavalier King Charles
spaniels (>5 years old) have a high prevalence of myoclo-
nus, which manifests most commonly as a brief jerking of
the head and forelimbs when the dog is standing or sitting.
Initially the syndrome is relatively benign but can be
progressive with affected dogs suffering frequent jerks
which may interfere with function, for example cause
the dog to fall or stumble [63]. The syndrome can be
confused with focal epileptic seizures but generally does
not respond to AEDs licenced for dogs although may re-
spond to levetiracetam (personal communication Clare
Rusbridge February 2015). The pathogenesis of the
myoclonus is as yet undetermined.
Collie (rough and smooth coated; or Scottish sheepdog
also known as Scottish Collie)
There is no specific epidemiological study for the Rough
and Smooth coated Collie available, but one study has
been published, which specifically focused on seizure
control in association to the ABCB1/MDR1-genotype in
epileptic Rough and Smooth coated Collies [64]. This
study was conducted in the USA and included 29 Rough
and Smooth Collies with suspected idiopathic epilepsy
[64]. The investigated population consisted of 25 Rough
coated Collies, 3 Smooth coated Collies, and 1 Collie
cross. Collies with an age of seizure onset between
6 months and 5 years of age and a minimum 6-month
history of AED administration were recruited for this co-
hort study [64]. All dogs had a presumptive diagnosis of
idiopathic epilepsy, which was made by the primary vet-
erinarian based on examination findings and laboratory
analysis [64]. A good seizure control was defined as ≤ 1
seizure/month and no occurrence of cluster seizures; a
poor seizure control was defined by > 1 seizure/month
or the occurrence of cluster seizures [64]. Among the in-
vestigated population 66 % received one antiepileptic
drug, 31 % received two antiepileptic drugs and 3 %
received three antiepileptic drugs. Overall, 38 % of dogs
were reported to have a poor seizure control, with a
mean seizure frequency of 3.9 seizures/month; the
remaining 62 % of dogs had a good seizure control with
a mean seizure frequency of 0.29 seizures/month.
Eighty-nine per cent of dogs with a good seizure control
were managed with a single AED and 50 % of those dogs
with a good seizure control became seizure free. Of
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the dogs with a poor seizure control 91 % had a history
of cluster seizures (=35 % of all dogs). Of all participat-
ing dogs, 48 % were homozygous for the ABCB1-/
MDR1-gene mutation (nt230 (del4)) (M/M), 38 % were
heterozygous for the mutation (M/N), and 14 % had the
wild-type genotype (N/N). The M/M group had signifi-
cantly better seizure control than the M/N or N/N
groups. However, as the M/N and N/N groups suffered
more frequently from antiepileptic drug adverse effects
than dogs from the M/M group (with non-significant
differences of antiepileptic drug serum concentrations
among all groups), the authors concluded, that the asso-
ciation of the M/M genotype with better seizure control
compared to the M/N or N/N (with poorer seizure
control) does not support the transporter hypothesis of
Pgp-mediated drug resistance in this breed. The authors
rather considered the association between genotype
and seizure outcome as an epiphenomenon, with the
ABCB1/MDR1-gene mutation being associated with a
less robust seizure phenotype that favours drug efficacy
in accordance to the intrinsic disease severity theory
[64]. However, Rough and Smooth coated Collies appear
to have a less severe clinical manifestation of idiopathic
epilepsy when compared with other breeds such as the
Australian Shepherd or Border Collie. Potential breed-
specific diseases that may mimic idiopathic epilepsy: As
mentioned above Rough and Smooth Collies are breeds
affected by ABCB1/MDR1-gene mutation, which needs
to be considered for dogs with very acute seizures and
potential previous exposure to neurotoxic P-gp sub-
strates. The frequency of homozygous affected dogs is
reported to range between 24 − 52 % depending on the
respective study and geographic area [33].
Dalmatian
To date, there is no study available that has specifically
evaluated idiopathic epilepsy in Dalmatians, but Short et
al. found that the Dalmatian was in the “top 14” of dog
breeds with epilepsy in the UK [46]. By contrast the Dal-
matian was not listed in the “top 20” of dog breeds rank-
ing in Kennel Club number registrations in 2011, which
suggests a predisposition to epilepsy [46]. Furthermore,
one study that reported clinical manifestations of natur-
ally occurring canine epileptic seizures also included
very detailed seizure data of 11 Dalmatians with prob-
able idiopathic epilepsy [65], and hence this breed was
included in the present manuscript. However, interpret-
ation of these data should be made with caution due to
the low number of investigated dogs. The latter study clas-
sified dogs as having probable idiopathic epilepsy if they
had had at least 1 seizure without any evidence of an
underlying cause. Specifically, the following conditions all
had to be met: the owner’s answers to health- related
questions revealed no illnesses or events (e.g., head
trauma) that could plausibly account for the seizures, at
least 1 year had passed since seizure onset during which
no interictal neurologic abnormalities were observed, and
the dog was between 6 months and 7.5 years old when sei-
zures began [65]. The median age at seizure onset among
those eleven Dalmatians was 2.9 years. The number of
Dalmatians was too small to reliably assess a potential
gender predisposition, however, 36.4 % of the dogs were
males and 63.6 % were females [65]. Among dogs, in
which owners were able to reliably report the initial stages
of an epileptic seizure, 20 % were reported to have (pri-
mary) generalised seizures and 80 % were reported to suf-
fer from focal or focal seizures evolving into generalisation
[65]. The mean seizure frequency was analysed with 9.7
seizures per year. At least one cluster seizure event was re-
ported in 63.6 % of dogs; further analysis revealed that
among dogs with cluster seizures the mean percentage of
total episodes that were clusters was 17.8 % [65]. Mean
duration of a generalised seizure was 3.3 min, whereas
mean duration of a focal seizure was 4.7 min. Mean
duration of a postictal phase after generalised seizures
was 16 min and after a focal seizure 0.9 min [65]. The
majority of dogs (72.7 %) received antiepileptic treat-
ment, but treatment response could not be assessed re-
liably because few dogs provided enough seizure
baseline data, making it impossible to evaluate their
overall response to treatment [65].
Dutch breeds
There are nine different Dutch pedigree breeds. Although
most of these breeds occur in the surrounding countries
of the Netherlands, all nine breeds are small in number,
increasing the risk of hereditary disorders [66, 67]. Re-
cently all case-record logs from the nine Dutch breeders
associations representing the nine Dutch breeds were
reviewed [68]. Dogs presented with epileptic seizures were
either classified as suffering from idiopathic generalised
tonic-clonic seizures or classified as focal epilepsy based
on their history, the clinical signs and diagnostic work-up.
There are four breeds, ‘Het Nederlandse Kooikerhondje’
‘Drentse Patrijshond’, ‘Stabyhoun’, and ‘Saarlooswolfhond’
with a higher incidence of idiopathic epilepsy [68]. Inter-
estingly the incidence of idiopathic epilepsy is, within the
other Dutch breeds, ‘Hollandse Herder (also called Dutch
Shepherd)’, ‘Smoushond’, ‘Het Nederlandse Markiesje, ‘Wet-
terhoun’, ‘Nederlandse Schapendoes’ remarkably low com-
pared with most pedigree breeds. Hollandse herder: the
incidence of generalised tonic-clonic epilepsy varied dur-
ing the last ten years around 0.25 %. The affected dogs are
presented between one to three years of age [68]. This
breed, that originates to before 1890, may have a small
common ancestry with the Belgian Shepherd dog [66] and
like the Belgian Shepherd dog different hair coat varieties
are recognised (shorthair, longhair and roughcoat).
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However, in contrast with the Belgian Shepherd the inci-
dence of idiopathic epilepsy is low in all varieties. Smoush-
ond: the incidence of dogs presented with generalised
tonic-clonic seizures was 0.7 % during the last 20 years.
Another 0.7 % of the dogs were presented with signs sug-
gestive of focal epilepsy but none of these dogs showed
secondary generalisation As the frequency of these focal
seizures remained low in these dogs it remains question-
able how to classify these dogs [68]. Het Nederlandse Mar-
kiesje: the incidence of idiopathic epilepsy appears to be,
with only 0.29 %. Within this breed a novel lethal neuro-
logical disorder has been identified in recently weaned
pups, with an incidence of 1 %, that has been classified as
a paroxysmal hyperekplexia [69]. Although affected dogs
remain conscious, the tonic rigidity of this disorder may
be confused with a myoclonic or tonic epilepsy [69]. Wet-
terhoun: this extremely small breed belongs to the group
of Retrievers and Water dogs and originated from the
Friesian area of the Netherlands. Although the number of
Wetterhouns bred annually is too small (between 60 an
150) to maintain a healthy population, the incidence of
generalised tonic-clonic epilepsy is extremely low: 0.1 %.
Similar figures have been found in the Nederlandse Scha-
pendoes (0.18 %) [68]. In contrast with these aforemen-
tioned five breeds that have a very low prevalence of
epilepsy, there are four other Dutch breeds that are more
greatly affected. The highest incidence has been found in
the Drentse Patrijshond. Within the Drentse Patrijshond,
a spaniel type of hunting dog, idiopathic epilepsy has been
reported since 1986 [70]. In 1986 the incidence of idio-
pathic generalised epilepsy was at least 1.4 %. If the inves-
tigators excluded a group with missing data the incidence
was calculated to be up to 9.4 %. Males and females were
equally affected, and the dogs, were between 9 months
and 5 years of age with a median of three years of age at
onset of seizures [70]. Affected dogs did not have a higher
inbreeding coefficient compared to the non-affected popu-
lation [70]. The hereditary grade (h2) was found to be be-
tween 0.33 and 0.47, which is highly suggestive for a
genetic origin. Recently, the number of affected animals
was again evaluated using the earlier described inclusion
criteria [68]. The incidence, calculated over the last
20 years currently varies between 3 to 5 %. The majority
of the affected dogs only have one to two seizures per time
period but a small number (<10 %) suffered from clusters
with more than three seizures per event [68]. In contrast
with the earlier study of Bobbert and Reekers [70] , dogs
could be presented up to 8 years of age before being iden-
tified as suffering from idiopathic epilepsy. As some of
these affected dogs already had been bred from, the inci-
dence of idiopathic epilepsy remains high. The Stabijhoun,
a Friesian type of spaniel hunting dog (also called ‘moles
dog’ as it is used to catch moles) had an average incidence
of 1.5 % over the last 15 years. Dogs were presented
between one and 5 years of age. Although not statistically
significant males appeared to be more affected than fe-
males (59 % males to 41 % females). Typically, the dogs
are presented with generalised tonic-clonic seizures.
Het Nederlandse Kooikerhondje, also called ‘Dutch
Decoy Dog’ as it is used as “decoy” to catch ducks [71]
was re-established after the 2nd World War and sub-
jected to a long period of intense inbreeding [72]. As a
consequence several, hereditary, neurological disorders
have been recognized in this breed [73]. The incidence
of idiopathic epilepsy, calculated for the last 14 years is
estimated to be 1.4 %. Males (71 %) appear to be over-
represented compared to females (29 %). The dogs are
normally presented between the age of 1 and 3 years
old [68]. The last breed, the Saarlooswolfhond, is a
breed established from a German Shepherd and Euro-
pean wolf hybrid and was created just before the 2nd
World War by Mr. Leendert Saarloos [66, 67]. The
population is very small and highly inbred, with in-
breeding coefficients varying between 25 to 60 %. A
total of 37 dogs have been identified suffering from
tonic-clonic seizures. The treatment response rate ap-
pears to be poor in this breed and up to 50 % suffer
from cluster seizures. Up to 50 % of these dogs were
euthanised, due too poor control of the seizures, within
two years after their first seizure [68]. As the breed is
highly inbred, selection against epilepsy is very challen-
ging. Currently the breeders are using, with permission
of the Dutch Kennel club, outcrossing to improve the
genetic variation within this breed [68].
English Springer Spaniel
In the current literature, one specific study about epi-
lepsy in English Springer Spaniels is available [74]. This
study was published in 2005 and provides data regarding
clinical characteristics and mode of inheritance of idio-
pathic epilepsy among an US English Springer Spaniel
population [74]. The latter study included 45 dogs diag-
nosed with idiopathic epilepsy. Idiopathic epilepsy was
defined as ≥2 seizures at least 1 month apart, without
any evidence of toxin exposure or head trauma, and re-
sults of routine serum biochemical testing and interictal
neurologic examinations were normal. Dogs in which
seizures first began at < 6 months or > 5 years of age
were considered to have idiopathic epilepsy only if CSF
analysis and CT or MRI had been performed and no
underlying cause of the seizures had been identified or if
2 years had lapsed since the onset of seizures without
any interictal neurologic abnormalities [74]. The median
age of seizure onset was reported as 3 years. A bimodal
age distribution was detected with one peak at 1–3 years
(60 %) and one peak at 5–6 years (20 %) [74]. There was
no significant gender predisposition [74]. The seizure
type was defined as (primary) generalised in 47 % of
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dogs and as focal or focal epileptic seizures evolving into
generalised seizures in 53 % of dogs. For the dogs with
focal seizures, 58 % of dogs had simple focal seizures,
38 % had focal epileptic seizures evolving into general-
ised seizures, and 4 % had complex focal seizures char-
acterized by stereotypic repetitive behaviours [74].
Applying the new seizure classification guidelines the
seizure type distribution would be: 47 % generalised epi-
leptic seizures, 33 % focal epileptic seizures and 20 %
focal epileptic seizures evolving into generalised epileptic
seizures. Seizure frequency ranged from 12 seizures per
month to 1 seizure every 2 years (median 5 seizures per
year). A history of cluster seizures was reported in 38 %
of dogs [74]. Sixty-seven per cent of the dogs received
an antiepileptic drug treatment. Treatment response was
assessed subjectively based on the owners‘opinion with a
reported good response in 23 % of treated dogs, a mod-
erate response in 47 % of dogs and a poor response in
30 % of dogs [74]. Detailed prevalence data have yet not
been provided for this breed. However, one epidemio-
logical study conducted in the UK reported 2.3 % Eng-
lish Springer Spaniels among 1260 dogs with epilepsy
and reported a high incidence of cluster seizures [46].
Similarly, another UK study found that the English
Springer Spaniel was one of the most commonly epi-
lepsy affected purebreds [17]; however, it must be con-
sidered that the English Springer Spaniel is a popular
breed in the UK, and thus may be overrepresented in
this population in general. In contrast to the UK epi-
demiological studies, the English Springer Spaniel 2013
UK Breed Health survey found that the prevalence of
epilepsy was 0.6 % (26 of 4327 dogs) [75]. Epilepsy was
reported as occurring in young and middle aged dogs, of
which 18 were male and 8 female. However in the mor-
tality section of this survey (dogs which had died be-
tween 1st January 2008 and 31st July 2013) epilepsy was
reported as the cause of 3.2 % of all deaths [75]. Many
of the deaths were young dogs and consequently the UK
breed club expressed concern about the disease and its
impact. Pedigree analysis and results of segregation ana-
lysis of the US study were consistent with a partially
penetrant autosomal recessive or polygenic inheritance
[74]. The identification of a causative gene mutation has
not yet reported [76]. Potential breed-specific diseases
that may mimic idiopathic epilepsy: Fucosidosis is a lyso-
somal storage disease, which affects humans and English
Springer Spaniels. The disease is autosomal reces-
sively inherited in both species and results from a
deficiency of the enzyme alpha-L-fucosidase [77, 78].
Affected English Springer Spaniels present with behav-
ioural changes and signs of motor dysfunction that start
at one to two years of age. Behavioural changes may mani-
fest as bizarre behaviour patterns, aggression or unusually
depressed mental state, and affected dogs appear to forget
previously learned behaviours [77]. These behavioural
changes may carry a risk of mistaking focal epileptic sei-
zures as a potential differential in the early stage of the
disease. However, Fucosidosis progresses rapidly, and
death or euthanasia usually occurs within a few weeks
from the onset of clinical signs [78]. A genetic test for
Fucosidosis is available [79].
Finnish Spitz
Four specific studies about epilepsy in Finnish Spitz dogs
are currently available [80–83], reporting prevalence,
clinical characteristics, mode of inheritance, imaging
findings and EEG findings. One prospective epidemio-
logical study published in 2013 reported an epilepsy preva-
lence of 5.4 % among the Finnish Spitz dog population in
Finland that were still alive [82]. This epidemiological
study provided data regarding phenotype, inheritance and
risk factors for idiopathic epilepsy of 141 affected Finnish
Spitz dogs. For this study idiopathic epilepsy was defined
as at least 2 seizure episodes without interictal neurologic
abnormalities; with data collected by questionnaires and
telephone interviews [82]. The latter study detected a sig-
nificant gender predisposition with 60.1 % males and
39.9 % females compared to a control population [82].
The median age of seizure onset was 3 years [82]. The me-
dian seizure frequency was 2 seizures per year. A history
of cluster seizures was reported for 16.2 % of dogs. The
seizure type was defined as focal epileptic seizures in 54 %
of the dogs, as focal epileptic seizures evolving into gener-
alised seizures in 31 % of the dogs and as (primary) gener-
alised epileptic seizures in 1 % of the dogs [82]. In 7 % of
dogs the seizures were generalised but with unknown on-
set and in an additional 7 % of dogs the seizure type was
unclassified. The median seizure duration was long at
11.75 min (occasionally ≥ 40 min). The disease course was
reported as non-progressive in 67.8 % of the dogs and
treatment response was assessed as good in 78.9 % of the
dogs [82]. The heritability was estimated at 0.22 and,
hence, a complex pattern of inheritance such as polygenic
recessive or autosomal recessive with incomplete pene-
trance was suggested [82]. Another study conducted in
2006 focused on EEG and MRI findings in 11 affected
Finnish Spitz dogs [81]. Among those dogs the seizure
type again predominantly was defined as focal epileptic
seizure or as focal epileptic seizure evolving into gener-
alised epileptic seizures (in 73 % of the dogs), with the
majority of dogs experiencing the latter seizure type
[81]. In 23 % of dogs, episodic behavioural changes were
present that lasted for only a few minutes such as dis-
orientation, fear and compulsive walking. These epi-
sodes were classified as focal seizure activity, since
consciousness was altered during these episodes [81].
Based on the predominant focal seizure type the term
focal idiopathic epilepsy was proposed. On EEG
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examination, focal epileptic activity was found in 64 %
of dogs, and generalised epileptic activity was observed
in 36 % of dogs [81]. On MRI examination, contrast en-
hancement was detected within the right parietal cortex
in one of the dogs, but was suggested to be a reversible
postictal finding, as such changes were not observed in
repeated MRI examination of the same dog [81]. The
remaining dogs showed no MRI abnormalities [81]. An-
other EEG study from 2007 – including 15 affected
Finnish Spitz dogs – reported that paroxysmal activity
seems to originate from a caudal-occipital location [80].
Furthermore, the EEGs of dogs with epilepsy exhibited a
significant difference in background frequency bands
compared with healthy control dogs; and beyond that,
phenobarbital treatment in affected dogs was identified
to markedly influence all background activity bands
[80]. Recently, a FDG-PET-study has been published
that investigated 11 affected Finnish Spitz dogs diag-
nosed with focal idiopathic epilepsy and six healthy con-
trols [83]. This study identified that epileptic dogs had
significantly lower standardized uptake values in numer-
ous cortical regions, the cerebellum, and the hippocampus
compared to the control dogs. The lowest standardized
uptake values were found in the occipital lobe. Thus, the
authors of this study suggested the use of FDG-PET as a
diagnostic tool for Finnish Spitz dogs with suspected idio-
pathic epilepsy [83]. Identified risk factors: A generalised
seizure phase was determined to be a risk factor for devel-
opment of progressive disease [82]. Predisposing factors
associated with the occurrence of seizure generalisation
were the age of onset (≤3 years), duration of the seizure
(1–10 min and ≥ 20 min), number of feeding times per
day (only once per day), and when the dog was used for
hunting [82].
Golden Retriever
Three studies focusing specifically on idiopathic epilepsy
in Golden Retrievers –all conducted in Switzerland –
have been published in the veterinary literature to date
[84–86]. These studies provide information about clin-
ical manifestation, heritability and EEG characteristics.
Based on the study, 25 affected dogs [86], 36 affected
dogs [84] or 5 affected dogs [85] were included, respect-
ively. Prevalence data have not been reported to date,
but the Golden Retriever was among the most common
affected breeds in an UK epidemiological epilepsy study
[17]; however, this may be due to the Golden Retriever
being a very popular breed in the UK. Depending on the
respective study the mean age at seizure onset ranged
between 27.5 months (≈2.3 years) [84] and 24.9 months
(≈2 years) [86]. The 1994 study, was a retrospective co-
hort study, that diagnosed idiopathic epilepsy when nor-
mal results on clinical, neurological, laboratory, CSF and
EEG examinations were evident [84]. This study found a
significant gender predisposition for male dogs (ratio 3.5:1),
but only when a distribution of 1:1 for the general dog
population was assumed [84]. Generalised epileptic seizures
were reported as the most common seizure type among all
of the studies with 83 % [86] and 92 % [84], respectively,
but a detailed distinction between (primary) generalised
epileptic seizures and focal epileptic seizures evolving into
generalised epileptic seizures was not provided [84, 86].
Hence, a proportion of dogs may have suffered from focal
epileptic seizures evolving into generalised epileptic seizures
instead of (primary) generalised epileptic seizures. A long-
term treatment study from 1999 included epileptic dogs
when they had at least 2 epileptic seizures, normal clinical
and neurological examination, normal routine blood work,
normal urine analysis and normal CSF analysis. Dogs that
were pre-treated with antiepileptic treatment were excluded
from the study [86]. The mean seizure frequency was re-
ported with one seizure every 16 days in the latter study
[86]. A good initial treatment response to phenobarbital
was observed in most of the dogs, however, after 4 years,
treatment response was poor with almost half (43 %) of the
dogs being euthanized [86]. The mean survival time after
diagnosis was 46 months (≈3.8 years) among phenobarbital
treated dogs [86]. A continuous positive impact of castra-
tion/neutering on seizure course was not found in any of
the studies (although in few dogs a transient improvement
was initially noted) [84, 86]. An EEG study from 1996 fre-
quently identified spindles in all recordings of five exam-
ined epileptic Golden Retrievers [85]. Early data already
suggested a genetic base for this breed, based on an in-
creased idiopathic epilepsy prevalence of certain subpopula-
tions and a repeated occurrence in different families of the
same sires [84]. Based on pedigree analyses and binomial
testing an autosomal multifactorial recessive mode of inher-
itance was suspected [84]. The identification of a causative
gene mutation has not yet been reported. Identified risk
factors: Treatment response was better the earlier an anti-
epileptic treatment was initiated and the lower the pre-
treatment seizure frequency [86]. Potential breed-specific
diseases that may mimic idiopathic epilepsy: One study
that investigated EIC among several dog breeds (Labrador
Retrievers and non-Labrador retriever breeds) identified
some Golden Retrievers diagnosed with EIC; however, a
DNM1-gene mutation was not identified in any of the af-
fected Golden Retrievers [30]. In contrast to epileptic sei-
zures EIC usually is triggered by strenuous exercise and
mental status predominantly remains normal during epi-
sodes, which may help a clinician to differentiate between
both diseases.
Hungarian (Magyar) Vizsla
To date, one study about clinical characteristics and in-
heritance of idiopathic epilepsy in Hungarian (Magyar)
Vizslas has been published in 2003 [87]. This study was
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conducted in the United States and summarised infor-
mation on 29 Hungarian (Magyar) Vizslas diagnosed
with idiopathic epilepsy and 114 non-affected siblings
and parents [87]. Idiopathic epilepsy was defined on the
basis of a dog having 2 or more seizures occurring at
least 1 month apart, no evidence of toxin exposure or
head trauma, normal serum chemistry results, and a
normal neurologic examination. For dogs with an age at
seizure onset <6 months or >5 years, unremarkable find-
ings on CT or MRI scans and CSF analysis were re-
quired [87]. Five dogs underwent CSF analysis and three
dogs had brain-imaging studies [87]. Prevalence data are
yet not reported for this breed, but among 1260 dogs
with epilepsy in the UK 0.6 % were Hungarian (Magyar)
Vizslas [46]. No significant gender predisposition was
found with 59 % males compared to 41 % females [87].
The median age of seizure onset was 3 years. The seiz-
ure type was defined as focal epileptic seizures in 79 %
of dogs and as generalised epileptic seizures in 21 % of
dogs. In 22 % of those dogs with focal epileptic seizures,
the seizures evolved into generalised epileptic seizures.
In other words, 62 % of dogs had focal epileptic seizures,
17 % of dogs had focal epileptic seizures evolving into
generalised seizures and 21 % had generalised epileptic
seizures. Initial focal epileptic seizure signs consisted
of a combination of limb or head tremors, staring, my-
driasis, lip smacking, salivating, facial twitching and/or
vomiting [87]. Two dogs, diagnosed with focal seizures,
exhibited fly-biting episodes which responded to antiepi-
leptic drugs [87]. The median seizure frequency for the
study population was 9 seizures per year. Forty-eight per
cent of the 29 epileptic dogs received antiepileptic drug
treatment with 21 % of those being not well controlled
based on their owners subjective opinion [87]. The seg-
regation analysis was consistent with an autosomal re-
cessive inheritance; however, polygenic inheritance could
not be excluded [87]. Pedigree analysis revealed that all
affected dogs could be traced back to a common sire.
The identification of a causative gene mutation has not
yet reported [76, 87].
Irish Wolfhound
In the current literature, one study is available that pro-
vides information regarding heritability and clinical char-
acteristics of idiopathic epilepsy in Irish Wolfhounds [24].
The latter study was published in 2006 and conducted in
the United States [24]. The diagnosis of idiopathic epilepsy
was made based on a history of more than 2 seizures
in the absence of other medical problems. Absence of
other medical problems was confirmed for all affected
dogs by normal physical and neurologic examination
results, CBC, serum biochemical analysis, ammonia or
bile acid values or both, and urine analysis. Dogs were
considered unaffected if no seizure had been observed
during the dog’s lifetime. Seizure-free dogs that died be-
fore the age of 4 years and dogs who had seizures in the
presence of seizure-associated conditions or diseases,
compatible with metabolic seizures or structural epilepsy
were excluded from the study [24]. Among a population
that contained 796 Irish Wolfhounds, 146 dogs with idio-
pathic epilepsy were identified, leading to an estimated
epilepsy prevalence of 18.3 % [24]. In 73 % of dogs the age
at seizure onset was under three years old, with males hav-
ing a later average age at seizure onset than females [24].
The seizure type was predominantly defined as general-
ised, but a precise description of seizure onset signs (e.g.
focal epileptic seizures evolving into generalised seizures)
was not provided. A gender predisposition towards males
was found (61.6 % affected males versus 38.4 % affected
females) compared to the control population [24]. The life
expectancy of epileptic individuals compared to the gen-
eral life expectancy of Irish Wolfhounds (provided by an-
other study [88]) was reduced by two years [24]. The
average inbreeding coefficient (calculated throughout 10
generations) for all the dogs entered into the study was
0.156 [24]. The heritability index for the affected dogs,
their littermates, and unaffected parents was calculated at
0.87. Pedigree analysis and segregation analysis were best
compatible with a complex pattern of inheritance such as
an autosomal recessive trait with incomplete penetrance
[24]. The identification of a causative gene mutation has
not yet been reported. Potential breed-specific diseases
that may mimic idiopathic epilepsy: Hyperekplexia (also
known as startle disease), which has been described in
Irish Wolfhounds is a disease characterized by noise- or
touch-induced episodes of muscle stiffness and apnoea
[89]. In affected pups clinical signs start 5–7 days post-
partum and manifest with handling-evoked extensor
rigidity and tremor. A micro-deletion of a presynaptic
glycine-transporter-gene (GlyT2, SLC6A5) has been identi-
fied in affected Irish Wolfhound puppies [89]. Beside star-
tle disease, a genetic predisposition for intrahepatic
portosystemic shunts has been reported for the Irish Wolf-
hound [90]. Therefore potential hepatic encephalopathy
needs to be considered in young Irish Wolfhounds that
present with seizures [90]. In addition to portosystemic
shunts a transient idiopathic hyperammonemia (with
normal bile acid testing) due to urea cycle enzyme defi-
ciency has been reported in Irish Wolfhound puppies
[91, 92]. However, whether this transient and usually
only moderate hyperammonemia may also contribute to
seizures has not been investigated in detail, but may be
considered in Irish Wolfhounds puppies with seizures
and normal bile acid testing.
Italian Spinone
Very recently, the Italian Spinone was reported to be
affected by idiopathic epilepsy [93]. A population study
Hülsmeyer et al. BMC Veterinary Research  (2015) 11:175 Page 16 of 28
was conducted to estimate the prevalence of idiopathic
epilepsy in the Italian Spinoni in the UK and to investigate
predictors of survival and seizure remission. The owners
of all UK Kennel Club registered Italian Spinoni were in-
vited to complete a phase I questionnaire. The phase I
questionnaires, the primary veterinarian’s, and, when
available, the veterinary neurologist’s medical records (in-
cluding results of diagnostic investigations) were reviewed
by the investigators to identify Italian Spinoni with idio-
pathic epilepsy and obtain data on treatment and survival.
Additional information on various aspects of epilepsy (in-
cluding seizure phenomenology and frequency) was ob-
tained from owners of epileptic Italian Spinoni who
completed the phase II questionnaire. The phase I ques-
tionnaire was returned for 1192 Italian Spinoni, of these,
63 Italian Spinoni were identified with idiopathic epilepsy.
The prevalence of idiopathic epilepsy in the Italian Spi-
noni in the UK was estimated as 5.3 %. Mean age at first
seizure was 38 months (median: 35 months). The gender
distribution of the epileptic dogs was 67 % males and 33 %
females (male to female ratio 2:1), but was not compared
to the general Italian Spinone population. The phase II
questionnaire was returned for 47 (75 %) of the 63 idio-
pathic epileptic Italian Spinoni. The most common seizure
type was generalised tonic-clonic seizures with impaired
consciousness and autonomic manifestations (e.g., in-
creased salivation, urination, defecation) for all 47 Italian
Spinoni. Focal epileptic seizures evolving into generalised
epileptic seizures were consistently recognized by the
owners of 24 Italian Spinoni (51 %). Cluster seizures and
status epilepticus occurred anytime in life in 46 (73 %)
and 13 (21 %) Italian Spinoni, respectively. Seizure remis-
sion occurred in 3 (6 %) of the 47 Italian Spinoni whose
owners returned the phase II questionnaire. Successful an-
tiepileptic drug treatment with good seizure control was
reported to be challenging in many instances. The identifi-
cation of a causative gene mutation has not yet reported,
but genetic analyses are currently in progress [93]. Identi-
fied risk factors: Survival time was significantly shorter in
Italian Spinoni euthanised because of poorly controlled
epilepsy compared with epileptic Italian Spinoni that died
of unrelated disorders. Survival was significantly longer in
Italian Spinoni with no cluster seizures and in Italian Spi-
noni in which antiepileptic medication was initiated after
the second seizure rather than after ≥3 seizures [93].
Labrador Retriever
Three studies investigating idiopathic epilepsy in the Lab-
rador Retriever are currently available; two Swiss [94, 95]
and one Danish [26] study. All three studies focus on dif-
ferent aspects of heritability and clinical characteristics.
The Swiss studies were cohort studies and idiopathic
epilepsy was defined by occurrence of more than one
(or two) seizures (depending on study) and normal
findings on physical examination, neurological examin-
ation, routine blood work, urine and CSF analysis [94, 95].
The two Swiss studies include 54 [94] and 55 [95]. Labra-
dor Retrievers with idiopathic epilepsy, respectively, and
they do not provide prevalence data [94, 95]. The Danish
study [26] is an epidemiological cross sectional population
study, which investigated a reference population of 29,602
Labrador retrievers registered in the Danish Kennel Club
in a ten year period. From the reference population a rep-
resentative sample of 550 dogs were selected for by ran-
dom sampling stratified by year of birth. After
questionnaire interviews of all 550 dog owners and clinical
investigation of dogs, suspected with epilepsy, 17 dogs
were finally identified with idiopathic epilepsy giving a
prevalence of 3.1 % among the investigated Danish popu-
lation [26]. No gender predisposition or positive effects of
castration on epilepsy course was detected in the Swiss or
the Danish studies [26, 94, 95]. The Danish study reported
the seizure type as generalised epileptic seizures in 24 % of
dogs and as focal epileptic seizures or focal epileptic sei-
zures evolving into generalised seizures in 70 % of dogs.
Among the latter 70 % of dogs focal epileptic seizures
were rare, whereas focal epileptic seizures evolving into
generalised seizures were predominant [26]. In both Swiss
studies the seizure type was reported to be generalised in
almost all the dogs (91 % [94] and 96 % [95], respectively)
and only 9 % presented with focal epileptic seizures [94].
But, the latter two Swiss studies did not distinguish be-
tween (primary) generalised epileptic seizures and focal
epileptic seizures evolving into generalised seizures; and
preictal signs were reported in a substantial number of
dogs (which were not considered as part/onset of a seiz-
ure), which may explain the discrepancy to the seizure
type found in the Danish study. Age at seizure onset was
reported with a mean age of 30.6 months in one of the
Swiss studies [95], with a mean age of 34 months for males
and 28 months for females in the other Swiss study [94],
and with 76 % of dogs having the first seizure by the age
of 4 years in the Danish study [26]. The average seizure
frequency in one of the Swiss studies was one every
65 days in dogs with generalised seizures and one every
205 days in dogs with focal seizures, however, approxi-
mately half of the dogs had seizures more than once a
month [94]. Pedigree analysis was best compatible with a
polygenic, recessive inheritance according to one of the
Swiss studies [95]. The identification of a causative gene
mutation has not yet been reported. Identified risk factors:
The 1997 Swiss study found that Labrador Retrievers with
a higher age at seizure onset showed a good treatment re-
sponse, even if treatment began late. Dogs with low seiz-
ure frequencies and low total numbers of seizures
responded well to therapy if treated as early as possible.
Untreated dogs mostly showed a progressive disease
course [94]. One study that examined inhibitory and
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excitatory neurotransmitters in the CSF of epileptic
Labrador Retrievers, epileptic non-Labrador Retrievers
and non-epileptic control dogs, identified that CSF con-
centrations of γ-aminobutyric acid (GABA) and glutamate
(GLU) were significantly lower in Labrador Retrievers with
idiopathic epilepsy than in a control-group of non-
epileptic dogs as well as in non-Labrador Retriever dogs
with idiopathic epilepsy [96]. However, the GLU to GABA
ratio was significantly higher in epileptic Labrador Re-
triever than in epileptic non–Labrador Retriever dogs.
It was suggested that an imbalance between GABAergic
inhibition and excitation by glutamate (indicated by the
high GLU-GABA ratio) in epileptic Labrador Retrievers
may be involved in the epileptogenic processes in this
breed [96]. However, whether those findings are the
cause or the consequence of seizure activity or a com-
bination of both cannot be concluded and still need to
be further elucidated. Potential breed-specific diseases
that may mimic idiopathic epilepsy: For the Labrador
Retriever EIC, predominantly caused by a DNM1-gene
mutation, needs to be considered as potential differen-
tials for epileptic seizures. Several studies suggest the
existence of another and “DNM-1-independent” EIC
condition in Labrador Retrievers, as some of the EIC-
affected Labrador Retrievers are negative or heterozy-
gous for the DNM1-gene mutation (approximately
15–30 % of EIC affected Labrador Retriever) [97, 98].
Hence, two distinct terms have gained acceptance for
Labrador Retrievers: d-EIC (homozygous DNM1-gene
mutation) and non-d-EIC (negative or heterozygous for
the DNM1-gene mutation) [30, 97, 98]. Apart from a
suspected diverse genetic background for the latter two
EIC types, clinical differences between d-EIC and non-
d-EIC have been observed. However, in general, and
in contrast to seizures, EIC-episodes are induced by
strenuous exercise. Contrary to epileptic seizures
muscle tone is initially decreased in the affected limbs
and consciousness remains preserved in more than
80 % of the Labrador Retriever with d-EIC. Another
study also reported a wide-based pelvic limb stance,
crouched posture and falling to the side during d-EIC
[99]. For non-d-EIC, the collapse episodes are re-
ported to occur at an older age, furthermore abnor-
mal mentation and involvement of all limbs are
observed more frequently58. A gene test for d-EIC in
Labrador Retrievers is available [30]. Narcolepsy with
cataplexy, which may potentially mimic a seizure
event, has also been reported in Labrador Retrievers
[100, 101]. However, in contrast to seizures a clinical
hallmark of narcolepsy, are sudden episodes of muscle
atonia triggered by excitement such as presentation of
food. Another disease that may mimic seizure epi-
sodes in Labrador Retriever puppies is familial reflex
myoclonus, in which the affected puppies present
with spasticity and opisthotonus at the age of 3 weeks
[102], especially when handled or lifted up. In gen-
eral, the Labrador Retriever breed is not known to be
predisposed for NCL, however, one case report exists
reporting an eight year old Labrador Retriever diag-
nosed with NCL on necropsy [103]. This dog had a
11-month history of progressive focal seizures with
generalised seizures at the end stage of the disease
[103]. Rapid eye movement (REM) sleep disorder is
another potential differential when assessing an epi-
leptic Labrador Retriever, with one case report of a 9-
month-old Labrador retriever cross presenting with two
morphologically distinct types of seizure episodes, one that
occurred only during sleep and one that occurred only when
awake. An EEG identified that the sleep-associated episodes
occurred during REM sleep, consistent with a diagnosis of
a REM behaviour disorder, which was improved with a tri-
cyclic antidepressant medication. The waking episodes were
diagnosed as epileptic seizures, as there was a clinical
response to antiepileptic medication [104].
Lagotto Romagnolo
To date three studies about clinical signs, heritability
and FDG-PET imaging findings in benign familial ju-
venile epilepsy in the Lagotto Romagnolo dog have
been published [105–107]. The first study was pub-
lished in 2007 and focused on clinical characteristics
and clinical course, which both appeared to resemble
the human form of benign familial juvenile epilepsy
[105]. The latter study included 25 Lagotto Romagnolo
puppies with (simple or complex) focal seizures and 3
adult Lagotto Romagnolo dogs exhibiting similar clin-
ical signs [105]. However, prevalence data are yet not
available. The mean age of seizure onset is reported as
6.3 weeks of age (with most puppies being affected by
1–2 month of age). The benign disease course is char-
acterized by a spontaneous seizure remission by 8 to
13 weeks of age [105]. The epileptic seizures manifest
with episodic stiffness, generalised tremor and a pre-
dominantly preserved consciousness. Although this
seizure semiology is a rather uncommon presentation
for epileptic seizures, epileptiform EEG activity was
detected in affected puppies [105]. Puppies that were
severely affected also suffered from interictal ataxia and
hypermetria. The seizure frequency varied from mul-
tiple episodes per day to one episode per week. A
gender-predisposition was not found. Histopathologic
examination in one puppy and one adult dog, revealed
Purkinje cell inclusions and vacuolation of axons re-
stricted to the cerebellum [105]. A simple autosomal
recessive inheritance was best compatible with pedigree
analysis [105]. Using a genome-wide association study
the disease locus was mapped to chromosome 3 where
a protein-truncating mutation in the LGI2 gene was
Hülsmeyer et al. BMC Veterinary Research  (2015) 11:175 Page 18 of 28
identified in 2011 [106]. The latter study showed that
LGI2, like the human analogue epilepsy gene LGI1, is
neuronally secreted and acts on metalloproteinase-
lacking members of the ADAM family of neuronal re-
ceptors, which function in synapse remodelling. It was
identified that LGI2 truncation, like LGI1 truncations,
prevents secretion and ADAM interaction [106]. LGI2
was highly expressed in the immediate post-natal
period until halfway through pruning, unlike LGI1,
which is expressed in the latter part of pruning and be-
yond. LGI2 acts at least in part through the same
ADAM receptors as LGI1, but earlier, ensuring elec-
trical stability during pruning time, preceding this same
function performed by LGI1 later in life [106]. Hence,
this functional LGI2-to-LGI1 transition may explain the
benign and remitting course of epilepsy in the Lagotto
Romagnolo breed. A genetic test is available for Lagotto
Romagnolos. One study among a large Lagotto Romag-
nolo population from 3 different countries identified
32 % dogs as disease carriers [106]. It should be noted
that in a small proportion of dogs seizures occurred at
an adult age [105]. However, in almost all of these adult
cases no LGI2 gene mutation was identified, suggesting
that there might exist a second and distinct form of
epilepsy in the Lagotto Romagnolo [106]. One recent
study focussed on FDG PET-imaging in affected
Lagotto Romagnolos [107]. Visual analysis revealed
areas of hypometabolism interictally in five out of six
dogs with juvenile epilepsy in the occipital, temporal,
and parietal cortex. Epileptiform EEG activity occurred
in three of these dogs in the same areas where PET
showed cortical hypometabolism [107]. Visual analysis
showed no abnormalities in cerebral glucose uptake of
dogs with adult-onset epilepsy, which further supports
the theory of another etiologically different form of
genetic epilepsy in this dog breed [107]. Apart from the
structural epilepsies that result from neurodegenerative
diseases such as progressive myoclonus epilepsy or
NCL, the Lagotto Romagnolo is the first dog breed
where an idiopathic epilepsy causative gene mutation
has been identified. Potential breed-specific diseases
that may mimic idiopathic epilepsy: One report
describes 2 Lagotto Romagnolo puppies diagnosed with
cerebellar cortical abiotrophy, which might be consid-
ered as potential differential to benign familial juvenile
epilepsy in this dog breed [108]. However, in cerebellar
cortical abiotrophy the clinical (cerebellar) signs were
reported as rapidly progressive or progressive followed
by a static phase with no evidence of an episodic nature
[108], which contrasts the episodic signs and remitting
disease course evident in benign familial juvenile epi-
lepsy [105]. In one of the cerebellar cortical abiotrophy
affected puppies the cerebellum was slightly decreased
in size on MRI examination of the brain [108].
Petit Basset Griffon Vendeen (PBGV)
One retrospective epidemiological population study in-
vestigating clinical characteristics and prevalence of epi-
lepsy in PBGV dogs has been published in 2011
(including both living and deceased dogs) [25]. This
study was conducted in Denmark and included all PBGV
dogs (=820) registered in the Danish Kennel Club be-
tween 1999–2008. Idiopathic epilepsy was defined on
the basis of a dog having at least 2 seizures with a mini-
mum interval of 24 h and the dog having a typical epi-
leptic seizure phenomenology [25]. All dogs that were
defined as epilepsy positive after an interview validation
and that were still alive, were invited to participate in a
clinical evaluation at the study centre, which included
clinical examination, neurological examination and
blood samples analysed by CBC, serum biochemistry in-
cluding thyroid hormone concentration and urinalysis,
ECG and ultrasound of the heart by a cardiologist (n = 19).
A few owners were offered an MRI of their dog’s brain
(n = 3) [25]. Forty-two dogs were evaluated to be true
epilepsy cases and the epilepsy prevalence among the
Danish PBGV population was estimated at 8.9 % [25].
The median age at seizure onset was 2 years. The gen-
der distribution was 62 % males and 38 % females, but
there was no significant gender predisposition detected
(compared to the general PBGV population) [25]. The
seizure type was defined as focal epileptic seizures in
41 % of dogs and as focal epileptic seizures evolving
into generalised epileptic seizures in 52 % of dogs. In
5 % of dogs generalised epileptic seizures were identi-
fied and in 2 % of dogs the seizures remained unclassi-
fied. The most commonly reported focal seizure signs
included motor signs such as ataxia and contractions of
single muscle groups, autonomic signs such as vomit-
ing and salivation and paroxysms of behavioural signs
such as excessive attention seeking or standing with a
blank stare not responding to external stimuli. The typ-
ical seizure duration varied from one to three minutes.
A strong litter effect was demonstrated supporting the
hypothesis of a hereditary component of epilepsy in the
PBGV. Identification of a causative gene mutation has
not been reported [25].
Shetland Sheepdog
Three reports about epilepsy in Shetland Sheepdogs are
available in the current literature [109–111]. All studies
were conducted in Japan. The first study was published
in 2002 and reports about a large family of Shetland
Sheepdogs with natural occurring familial frontal lobe
epilepsy defined by EEG analysis and seizure semiology
[109]. Two litters of one large family were produced de-
liberately for prospective examination in this study. A
detailed definition for idiopathic epilepsy was not pro-
vided [109]. The age at seizure onset was predominantly
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between 1 and 1.5 years of age. The average seizure fre-
quency varied from one seizure every week to one every
6 months. The gender distribution was 79 % females
compared to 21 % males. The seizure type was predom-
inantly defined as generalised in almost all cases, but de-
tailed classification of initial seizures signs was not
conducted [109], hence a proportion of dogs might have
experienced focal seizures evolving into generalised sei-
zures instead of (primary) generalised seizures. EEG
examination identified paroxysmal discharges predomin-
antly in the frontal lobes [109]. Based on this, this epi-
lepsy was postulated as familial frontal lobe epilepsy,
however with prolonged disease duration also the par-
ietal, temporal and occipital lobes showed epileptiform
activity on EEG [109]. Pedigree analysis excluded poten-
tial mitochondrial or sex-linked inheritance and a multi-
factorial inheritance was suggested to be most likely
[109]. Identification of a causative gene mutation has
not yet reported. Additional findings of the latter study
were increased aspartate and glutamate levels in the CSF
in some of the epileptic dogs compared to control dogs
[109]. Hence, another study that was published in 2005
focussed on intracerebral microdialysis and EEG record-
ing as well as histopathological examination of epileptic
Shetland Sheepdogs [110]. Intracerebral microdialysis and
EEG – both conducted during hyperventilation – revealed
increased extracellular glutamate and aspartate concentra-
tions in the cerebral cortex of epileptic dogs. Coinciding
with the increase in excitatory neurotransmitters, an in-
crease in paroxysmal discharges on EEG was detected.
On histopathological examination, dogs affected by sta-
tus epilepticus showed a reduced density of glutamate
receptors in the area of the lateral nucleus of the thal-
amus. In addition, glutamate positive granules were
found within the perineural spaces of the cerebral cor-
tex. It was considered possible that a decrease of
glutamate receptor levels may induce an increase in
extracellular glutamate concentration, which would
evoke neuronal hyperexcitability and may contribute to
a collapse of extracellular glutamate regulation during
status epilepticus [110]. Another case report of a Shet-
land sheepdog with drug resistant epilepsy identified
hippocampal and mesial temporal lobe sclerosis on nec-
ropsy. However, this finding was suggested as a
secondary phenomenon induced by recurrent seizures
rather than to be a primary seizure-causing finding
[111]. Potential breed-specific diseases that may mimic
idiopathic epilepsy: For the Shetland sheepdog a spongi-
form encephalopathy has been reported, which appears
with neurological signs that may mimic a seizure event.
However, clinical manifestation is early within the first
weeks of life (between the 2– 9 weeks of life) and con-
sists of tremors, ataxia, paresis, spasticity and loss of
cranial nerve function. DNA sequencing of affected
puppies showed a point mutation that resulted in an
amino acid change of mitochondrial encoded cyto-
chrome b [112]. The Shetland sheepdog is also a dog
breed frequently affected by ABCB1/MDR1-gene muta-
tion, with identified mutant allele frequencies between
1 − 12 % depending on the respective study and geo-
graphic area [33], which may need to be considered in
Shetland sheepdogs with acute seizures and potential
previous exposure to neurotoxic P-gp substrates.
Standard Poodle
In the current literature, there are two studies available
that provide information about idiopathic epilepsy in the
Standard Poodle [65, 113]. One study, that was pub-
lished in 2007, reports clinical characteristics and mode
of inheritance of epilepsy in a large family of Standard
Poodles in the United States [113]. This study included
30 Standard Poodles diagnosed with probable idiopathic
epilepsy and 90 healthy controls. Dogs were defined as
having’probable idiopathic epilepsy’ if they had had at
least 1 seizure without any evidence of an underlying
cause. Specifically, the following conditions all had to be
met: the owner’s answers to health-related questions re-
vealed no illnesses or events (e.g., head trauma) that
could plausibly account for the seizures, at least 1 year
had passed since seizure onset during which no interictal
neurologic abnormalities were observed, and the dog
was between 6 months and 7.5 years old when seizures
began [113]. The term’probable’ was used because the
medical work up was insufficient to definitely exclude
other causes of epilepsy and because dogs that had expe-
rienced only a single seizure were also included [113].
No significant gender predisposition was detected be-
tween affected males (57 %) and females (43 %). The
median age at seizure onset was 3.7 years, however, 20 %
of all affected dogs had their first seizure after an age of
five years [113]. The seizure type could be determined in
29 dogs and was defined as focal epileptic seizures in
33 % and as focal epileptic seizure evolving into general-
ised epileptic seizures in 60 % of dogs [113]. Overall
93 % of the dogs had focal epileptic seizures or focal
epileptic seizures evolving into generalised seizures. In
3.5 % of dogs seizures were classified as (primary) gener-
alised epileptic seizures; in another 3.5 % of dogs the
epileptic seizures were generalised but the exact onset of
seizures could not be determined precisely [113]. As the
majority of dogs (93 %) among this family experienced
focal epileptic seizures or focal epileptic seizures evolv-
ing into generalised seizures, familial focal epilepsy was
suggested [113]. Focal epileptic seizures consisted of
shaking, jerking, or shivering; incoordination character-
ized by staggering or an inability to stand; stiffness or ri-
gidity; and unusual movements or body positions such
as a head tilt or awkward limb lifting. Autonomic signs
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included hypersalivation, panting, urination, and increased
heart rate. Some dogs also presented with increased anxiety
or automatisms such as licking, lip smacking, swallowing or
circling [113]. Only 13 % of the dogs received antiepileptic
drug treatment and all of them showed a good treatment
response. The segregation analyses suggested a recessive
autosomal inheritance with almost complete penetrance
[113]. All examined Standard poodles in the latter study
were closely related; hence, it is possible that there might
be different epilepsy courses and modes of inheritance in
geographically and genetically distinct standard poodle pop-
ulations. However, a frequent occurrence of focal or focal
epileptic seizures evolving into generalised seizures in
Standard poodles was already reported in an earlier study
from 2002 [65]; but the two studies (2002 and 2007) were
conducted by the same authors and it was mentioned that
few of the dogs were included in both studies. The study
from 2002 reported a median age at onset of 2.4 years, a
median seizure frequency of 2.8 seizures per year and a his-
tory of cluster seizures in 34.1 % of affected Standard Poo-
dles [65]. Identification of a causative gene mutation has
not yet been reported [65, 113]. Potential breed-specific dis-
eases that may mimic idiopathic epilepsy: For the Standard
Poodle, a neonatal encephalopathy with seizures (NEWS)
has been reported that may play a role as potential differen-
tial in Standard poodle puppies with seizures [114]. How-
ever, NEWS manifests immediately after birth with ataxia,
tremors and generalised tonic-clonic seizures. As a rule, af-
fected puppies die within the first two months of life. A
missense mutation in the canine orthologue of ATF2 has
been identified in affected puppies [114]. Polymicrogyria is
a rare malformation of the cerebrum characterized by
an excessive number of small, histologically anomalous
gyri and has been described in Standard Poodles [115,
116]. Affected dogs experience cortical blindness and
other neurologic abnormalities including abnormal
(hypermetria) gait and behavioural changes [115, 116]
and may be considered as differential in young Standard
Poodles that present with focal seizures or behavioural
changes. Neurological signs predominantly start at a
very young age (<4 months). MRI examination is con-
sistent with multiple disorganized gyri, which especially
may be seen on T2-weighted dorsal plane images [115].
EEG-examination of 1 dog revealed epileptiform
discharges, including both spike and spike and wave
discharges with voltage maximum potentials over the
parietal/occipital region, which supported the repetitive
behaviour as focal seizures [115].
German Shepherd, Beagle, Dachshund and Keeshond
There are a few older publications available that specific-
ally focus on epilepsy in German Shepherds, Beagles,
Dachshunds or Keeshonds [117–120]. Particularly for
the Beagle, it should be mentioned that most of the
earlier published data are based mainly on laboratory
dog populations [117]. However, one recent epidemio-
logical investigation and one genetic investigation sup-
port an increased risk for idiopathic epilepsy in Beagles
at present [22, 76]. In Beagles, Dachshunds (miniature
wirehaired) and Basset Hounds it is important to con-
sider the occurrence of progressive myoclonus epilepsy
(Lafora disease), as the latter is considered a neurode-
generative disorder and structural-metabolic epilepsy ra-
ther than idiopathic epilepsy [121–123]. In Dachshunds
(and Bassett Hounds) a gene test for progressive myo-
clonus (Lafora) epilepsy is available [124]. Data from the
Dachshund Breed council surveys in 2012 and 2015 sug-
gest a epilepsy prevalence of approximately 1 % but rising
to 3.7 % in miniature long haired Dachshunds (personal
communication Clare Rusbridge February 2015). For the
Keeshond, older studies proved a clear founder effect,
which was most likely consistent with an autosomal reces-
sive inheritance [120, 125], the median age at onset was re-
ported with 2 years and some EEG examination has been
made, however, further detailed clinical data are lacking.
There are no up-to date studies available about idiopathic
epilepsy in German Shepherds Dogs, but several current
epidemiological canine epilepsy studies have been published
that include interesting information for this breed. Most of
those epidemiological studies have been conducted in the
UK, and most of them identified the German Shepherd Dog
among the most common epilepsy affected breeds [17, 46,
47]. Another epidemiological study revealed the German
Shepherd Dog has an increased risk of cluster seizures com-
pared to other breeds like the Labrador Retriever [126].
Finally, it is important to consider that in addition to the
above mentioned dog breeds, there is strong clinical evi-
dence that many more purebreds, such as the Siberian
Husky, Staffordshire Bull Terrier, Boxer dog, Greater Swiss
Mountain dog, Schipperke and many others appear to be
affected by idiopathic epilepsy [10, 17, 22, 46, 47, 76]. It is
only a matter of time until detailed data regarding the
clinical characteristics and inheritance for those so far
“suspected” breeds will be published. Furthermore,
current epidemiological data suggest that beside pure-
bred dogs, crossbreeds with idiopathic epilepsy present
an increasing proportion among canine idiopathic epi-
lepsy populations [46].
Conclusion and future perspectives
The present manuscript was conceived to review current
knowledge of idiopathic epilepsy in purebreds with special
interest on breed-specific phenotypes including clinical
characteristics, disease course, seizure control and genetic
transmission. Some differences, and in parts even
contradicting findings became evident among breeds, and
even – at least to some degree – between geographically
distinct populations of the same breed. This may to some
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Table 4 Depicting variable study design
Breed Study N Study designs Case selection Inclusion criteria Exclusion criteria Investigations for confirmation
of idiopathic epilepsy
Australian Shepherd Weissl et al.
2012 [9]
50 Cohort, controls Questionaire &phone
interview
≥2 seizures≥ 4 weeks
apart, age at onset
≤ 5 years
History of skull trauma PE, NE, laboratory with bile acid
stimulation test
MRI/CSF (47 %)
Urinary organic/amino acids
(20 %)
Post mortem (4 %)
Belgian Shepherd Berendt et al.
2008 [23]
49 Population
survey (breed)
Questionnnaire (validated)
&phone interview
≥2 seizures n.s. n.s.
Seppala et al.
2012 [34]
94 Cohort, controls Questionnaire ≥2 seizures n.s. Detailed examination (18 %) [35]
PE, NE, laboratory
MRI/CSF
Descriptive: EEG (18 %)b
Oberbauer et al.
2003 [35]
164 Cohort
(family-based)
Owner-reported
generalized seizures &
questionnaire
≥2 seizures n.s. n.s.
Oberbauer et al.
2010 [36]
74 Cohort, controls Owner and veterinarian
reported generalized
seizures
≥2 seizures n.s. n.s.
Gullov et al.
2012 [37]
51 Cohort, controls
(family-based)
Questionnaire & phone
interview
≥2 seizures n.s. PE, NE, laboratory with thyroid
profile, ECG
Berendt et al.
2009 [41]
66 Cohort
(family-based)
Questionnaire & phone
interview
≥2 seizures History suggesting
intracranial disease
and progressive
neurological signs.
PE, NE, laboratory with thyroid
profile, ECG
Famula et al.
1997 [38]
23 Population
survey (breed)
Questionnaire 1 seizure n.s. n.s.
142 ≥2 seizures
Famula & Oberbauer
2000 [39]
21 Population
survey (breed)
Questionnaire 1 seizure n.s. n.s.
157 ≥2 seizures
Bernese Mountain Dog Kathmann et al.
1999 [45]
50 Cohort Questionnaire History of epileptic
seizures
n.s. PE, NE, laboratory with bile acid
stimulation test, CSF
Border Collie Hülsmeyer et al.
2010 [8]
49 Cohort Questionnaire & phone
interview
≥2 seizures, at least
4 weeks apart
Presence of any initial
precipitating event
(eg, head trauma), an
identified brain lesion,
or observational data
consisting of less than
10 h/day.
PE, NE, laboratory
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Table 4 Depicting variable study design (Continued)
Border Terrier Kearsley-Fleet et al.
2013 [17]
n.s. Population survey
(vet practice)
Electronic patient records ≥2 seizures for≥ 1 year, or Medical records documented
disease that could have
caused epilepsy including
brain imaging abnormalities
PE, laboratory
≥4 prescript- ions of AEDs
Kloene et al.
2008 [56]
47 Population survey
(breed)
Questionnaire n.s. n.s. PE, NE, laboratory with bile acid
stimulation testa (10 %)
CT/CSF (10 %)
Urinary organic/amino acids
(47 %)
Cavalier King Charles Rusbridge&Knowler
2004 [58]
40 Cohort, controls
(family
investigation)
Owner-reported seizures Diagnosis by veterinarian
(generalized seizures, AED)
Clinical signs of CM n.s.
Driver et al.
2013 [59]
29 Cohort, controls Medical record search
CKCS with CM
History of epileptic seizures MR lesions other than CM
or ventriculomegaly
Laboratory with bile acid
stimulation test, CSF, EEGb
Abnormal laboratory data
Collie Munana et al.
2012 [64]
29 Cohort Questionnaire Age of onset > 6 m/< 5 y,
> 6 m prescription of AEDs
Laboratory
Dalmatian Licht et al.
2002 [65]
11 Cohort Questionnaire & phone
interview
≥1 seizure Evidence for structural
epilepsy, seizures were not
seen from the beginning
PE, NE, laboratory, bile acid
stimulation test, tests for
suspected toxin exposure
English Springer Spaniel Patterson et al.
2005 [74]
45 Cohort Questionnaire & phone
interview
≥2 seizures, ≥ 4 weeks
apart
Evidence for head trauma
or toxin exposure
NE, laboratory age of onset
< 6 m />5 y: MRI or CT WNL
or > 2 y without interictal
abnormalities
Kearsley-Fleet
et al. 2013 [17]
n.s. Population survey
(vet practice)
Electronic patient records ≥2 seizures for ≥ 1 year, or Medical records documented
disease that could have
caused epilepsy including
brain imaging abnormalities
PE, CBC, biochemical profile
≥4 prescriptions of AEDs
Finnish Spitz Jeserevic et al.
2007 [80]
15 Cohort, controls ≥2 focal seizures PE, NE, laboratory
MRI/CSF (73 %), EEGb
Viitmaa et al.
2006 [81]
11 Cohort, controls ≥2 focal seizures Evidence for structural
epilepsy
PE, NE, laboratory, MRI/CSF, EEGb
Viitmaa et al.
2013 [82]
111 Population survey
(breed)
Questionnaire & phone
interview
≥2 seizure episodes Interictal neurologic
abnormalities,
onset < 1 y, only 1 seizure
episode
PE, NE, laboratory (27.8 %)
Viitmaa et al.
2014 [83]
11 Cohort ≥2 focal seizures PE, NE, laboratory
Golden Retriever Srenk&Jaggy
1996 [85]
5 Cohort, controls Questionnaire, medical
records review
History of epileptic seizures,
normal diagnostic tests
n.s. EEGb
Srenk et al.
1994 [84]
36 Cohort Questionnaire, medical
records review
History of epileptic seizures,
normal diagnostic tests
n.s. PE, NE repeatedly, laboratory with
bile acids or ammonia, CSF, EEG
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Table 4 Depicting variable study design (Continued)
Lengweiler&Jaggy
1999 [86]
25 Cohort Questionnaire ≥2 seizures n.s. PE, NE repeatedly, laboratory with
bile acids or ammonia, CSF
Hungarian (Magyar)
Vizsla
Patterson et al.
2003 [87]
29 Population survey
(breed)
Questionnaire ≥2 seizures, ≥ 1 month
apart
Evidence of toxin exposure
or head trauma
NE, laboratory
If < 6 m/ > 5 < y: CT /MRI/CSF
Irish Wolfhound Casal et al.
2006 [24]
146 Population survey
(families)
Questionnaire ≥2 seizures Other medical problems PE, NE, laboratory with bile acids
or ammonia or both post
mortem exam (10 %)
Italian Spinone DeRisio et al.
2015 [93]
63 Population survey
(breed)
Questionnaire ≥2 seizures, ≥ 24 h apart n.s. PE, NE, laboratory
onset >6 m / <6y
Labrador Retriever Heynold et al.
1997 [94]
54 Cohort (medical
records)
Questionnaire ≥2 seizures video
documentation (28 %)
PE, NE, laboratory with bile acids
or ammonia, CSF
Jaggy et al.
1998 [95]
55 Cohort, controls Questionnaire ≥2 seizures Other medical problems PE, NE, laboratory with bile acids
or ammonia, CSF at presentation
and at 6 month follow-up
Lagotto Romagnolo Jokinen et al.
2007 [105]
25 Cohort,
case–control
Breeder-reported
seizures families
Seizure episodes n.s. PE, NE, laboratory, MRI/CSF
EEG/EMG/BAERb
Post mortem (n = 1)
Petit Basset Griffon Gullov et al.
2011 [25]
42 Population survey
(breed)
Questionnaire (validated)
&
phone interview%
≥2 seizures, ≥ 24 h apart n.s. Laboratory, thyroid function,
cardiac exam (45 %) bile acid
stimulation test (21 %)
MRI (7 %)
Shetland Sheepdog Morita et al.
2002 [109]
11 Cohort (family) Prospective investigation Repeated seizures n.s. Laboratory
EEG on repeated occasionsb
CSF (64 %)
Post mortem (64 %)
Standard Poodle Licht et al.
2007 [113]
30 Population survey
(family)
Short questionnaire, &
phone interview,
6 months follow-up
≥1 seizure History of illness or head
trauma
that could account for seizures
≥1 year unremarkable follow-up
Age of onset <6 m/>7.5y
Licht et al.
2002 [65]
41 Cohort Owner-reported seizures ≥1 seizure Evidence for structural epilepsy,
seizures were not seen from
the beginning
PE, NE, laboratory, bile acid
stimulation test, tests for
suspected toxin exposureQuestionnaire & phone
interview
asome dogs with elevated bile acids; b EEG was used for descriptive purposes and not as a diagnostic test for IE
n.s. not specified, PE physical examination, NE neurological examination, MRI magnetic resonance imaging, CSF cerebrospinal fluid analysis, EEG electroencephalography, ECG electrocardiogram
H
ülsm
eyer
et
al.BM
C
Veterinary
Research
 (2015) 11:175 
Page
24
of
28
degree reflect the development over time in our under-
standing of epilepsy, different study designs (see Table 4)
and definitions for epilepsy and seizure terms that have
been applied and furthermore genetic diversity between
dog breeds and in some cases between geographically dis-
tinct populations of the same breed. Frequently, variable
study designs were evident, with individual studies con-
taining variable levels of disease-specific parameters (e.g.
analysing occurrence of cluster seizures or not) and more-
over data collections were performed in different ways
(e.g. prospectively versus retrospectively). In human medi-
cine, general guidelines and classification systems have
long been established under the care of the International
League Against Epilepsy. As these guidelines remain con-
stantly under progress and are kept updated over the
years, they have substantially promoted research and care
for epilepsy patients, especially by diagnosis and treat-
ment [127–133]. In recent years, strong efforts have
been made to classify and define epilepsy terms in veter-
inary medicine, in particular, the clinical classification of
different seizure types has been advanced by the appli-
cation of human medicine classification systems [2, 65,
134–137]. However, direct comparability between ca-
nine epilepsy studies remains limited to some degree,
due to the above mentioned issues, which point once more
to the need for generally accepted concepts and guidelines
for the conduct of epilepsy studies among the veterinary
community, under guidance of a specialised veterinary
epilepsy task force. The currently formed International
Veterinary Epilepsy Task Force has crafted several consen-
sus statements to help overcome these challenges in the
area of Classification, Diagnosis, Treatment, Neuroimaging,
Treatment outcomes, and Neuropathology. This might
help establish new consistent studies of breed-specific ca-
nine epilepsy phenotypes and syndromes, which in turn
may help to promote genetic analysis and to establish
novel antiepileptic drug treatment strategies.
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